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2, 3 
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ABSTRACT 
The  procedures  for  gaining,  maintaining,  suspending,  withdrawing  or  re-gaining  official  bovine 
tuberculosis free herd status and for certification for intra-Union trade are based on the results of 
tuberculin skin tests. The skin test has a number of drawbacks, therefore the suitability of the gamma 
interferon test and other tests to be included by EU legislation was assessed. Suitability means that the 
test has a sensitivity equivalent or superior to the standard test currently used in the European Union 
and specificity not lower than that of the standard test with the lowest specificity used in the EU. 
Furthermore,  there  should  be  no  foreseeable  practical  difficulties  that  could  compromise  test 
performance. It was concluded that purified protein derivative based gamma interferon tests can be 
included amongst the official tests for the purpose of demonstrating freedom. However, some results 
suggest that the specificity of the purified protein derivative based gamma interferon tests  may not 
always be as high as the single intradermal tuberculin test. In case the test is included, the protocols 
for its use for this purpose should be harmonised in the EU. Based on the reviewed information, other 
tests should not yet be considered for inclusion in the official tests for the purpose of granting and 
retaining official tuberculosis  free herd status. Further evaluation of the suitability of the  gamma 
interferon  tests  test  should  study  the  influence  of  factors  such  as  the  presence  of  environmental 
mycobacteria, prevalence of bovine tuberculosis in the herd, the age type and bovine tuberculosis test 
history of the animals all of which may affect test specificity and hence the suitability of the test for 
demonstrating freedom from bovine tuberculosis  in different situations. 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Animal  Health  and  Welfare 
(AHAW) was asked to deliver a scientific opinion on the use of a gamma interferon test (IFN-γ) for 
the  diagnosis  of  bovine  tuberculosis  (bovine  TB).  The  procedures  for  gaining,  maintaining, 
suspending, withdrawing or re-gaining official bovine TB-free herd status and for certification for 
intra-Union trade are laid down in Council Directive 64/432/EEC and are based on the results of 
tuberculin skin tests. The skin test has a number of drawbacks, in terms of test characteristics, limited 
sensitivity at the level of the individual animal and testing logistics.  
In this mandate, the first objective was to assess whether IFN-γ can be added to the official tests as a 
stand-alone test for demonstration of bovine TB-free herd status and testing for intra-Community 
trade. The IFN-γ should have a sensitivity equivalent or superior to the standard test currently used in 
the European Union and have a specificity not lower than that of the standard test with the lowest 
specificity used in the EU. Furthermore, there should be no foreseeable practical difficulties that could 
compromise test performance. In addition, any other tests that meet the above requirements should be 
identified. In the event that no new test could be recommended, the additional objective was to inform 
the Commission of further studies necessary to evaluate the suitability of the IFN-γ test or any other 
new test. 
Three different data sources were considered: (1) a systematic literature review and meta-analysis of 
studies on the  performance of bovine TB tests  carried out by the Animal Health and Veterinary 
Laboratories Agency (AHVLA); (2) new publications on test performance that had become available 
since the original searches for the AHVLA review; and (3) data from a public data call. Data from the 
public data call were analysed by a Bayesian latent class model that enables estimation of sensitivity 
and specificity in the absence of a gold standard test.  
The systematic literature review showed that the sensitivity of the IFN-γ test, based on standard 
purified  protein  derivative  (PPD),  was  not  significantly  different  from  that  of  the  comparator 
tuberculin skin test and, although the comparative skin test had the highest specificity, the specificity 
of the IFN-γ test was not significantly different from that of the standard skin test with the lowest 
specificity  currently  used  in  the  EU,  the  single  intradermal  test  (SIT).  New  publications  did  not 
change this overall picture. Latent class analysis demonstrated a higher sensitivity for the IFN-γ test 
than for the skin tests but at the cost of a lower specificity. Considerable differences in sensitivity and 
specificity across populations for both the IFN-γ and the skin test were observed, which may be 
explained by differences in the way tests are performed and interpreted and differences in the disease 
prevalence and distribution of stages of infection in the different populations. The probability that an 
animal or a herd is free of infection when a negative result is obtained from the IFN-γ test is at least as 
high as when a negative skin test result is obtained. However, considering the specificity estimates 
obtained, the probability that all animals in a herd will test negative in the IFN-γ test, given that they 
are free of bovine TB, may be lower than when skin tests are used for diagnosis of infection. The 
opinion  also  concluded  that,  within  the  EU  Member  States,  the  practical  requirements  for  the 
performance of the IFN-γ test can be met. Information regarding the sensitivity and specificity of IFN-
g test based on defined antigens is yet limited and the estimates of sensitivity and specificity of 
antibody tests are either very imprecise or based on only a few studies. 
According to the definition of suitability given above PPD based IFN-γ tests can be included amongst 
the official tests for the purpose of granting and retaining an officially tuberculosis free herd status. 
However, the results from the latent class analysis from the public data call suggest that the specificity 
of the PPD based IFN-γ may not always be as high as the SIT test, the  test with the lowest specificity 
currently used in the EU. The panel recommended that should the PPD based IFN-γ test be included 
in the official tests for the purpose of granting and retaining  official TB-free status, the protocols for 
its use for this purpose should be harmonised in the EU. bovine TB Test  
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Based on the reviewed information, other tests should not  yet be considered for inclusion in the 
official tests for the purpose of granting and retaining official TB-free herd status. 
Further evaluation of the suitability of the IFN-γ test should study the influence of factors such as the 
presence  of  environmental  mycobacteria,  prevalence  of bovine TB  in  the  herd,  the  age type  and 
bovine TB test history of the animals all of which may affect test specificity and hence the suitability 
of the test for demonstrating freedom from bovine TB in different situations. bovine TB Test  
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BACKGROUND AS PROVIDED BY EUROPEAN COMMISSION 
The  procedures  for  gaining,  maintaining,  suspending,  withdrawing  or  re-gaining  the  officially 
tuberculosis free (TBOF) herd status are laid down in Annex A to Council Directive 64/432/EEC of 
26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and 
swine (“the Directive”) and are based on the results of tuberculin skin tests carried out in bovine 
herds. In addition Member States or regions thereof may be declared TBOF if certain requirements 
are fulfilled. Annex В to the Directive sets up details of the diagnosis of bovine tuberculosis (TB). 
This Annex was thoroughly reviewed in 2002 to incorporate new diagnostic methods and to further 
align EU requirements to the international standards of the World Organisation for Animal Health 
(OIE). 
The tuberculin skin test in its various forms is the sole test prescribed in EU legislation. While this 
test has been an effective tool when applied at herd level, a lack of sensitivity at the individual animal 
level is recognised to be its limitation. An increase in the sensitivity (identifying fewer false test-
negative but infected animals that remain in a herd) of the test is achievable by changing the cut-off 
point of the test. However, specificity (Sp) of the test could be lowered (more false test-positive but 
healthy animals are removed from a herd) when the test is interpreted in a more stringent way. Few 
new diagnostic tests have been developed in the last 30 years but the IFN test has showed its value to 
detect infected animals in a relatively accurate manner under certain circumstances. Therefore, the use 
of a gamma interferon (IFN-γ) test as an ancillary test carried out concurrently and in parallel to the 
tuberculin skin test, is currently regulated in Annex B(3) to the Directive. However, the IFN-γ may 
only be used to detect the maximum number of infected animals in the target population. This limited 
and strategic use of the IFN-γ test increases the sensitivity of the diagnostic regime. Optimised use of 
the parallel testing (tuberculin skin test and IFN-γ test) may allow the detection of 2 out of every 3 
false tuberculin-negative infected animals that would otherwise be considered negative and thus not 
removed from the herd, if the tuberculin test alone had been used. In Europe in the last years IFN test 
has been used in the context of the EU co-financed eradication programmes and valuable information 
is now available on the performance of this test. The experience gained is not only limited to the use 
of the IFN-γ test using tuberculin PPD as antigen but also with other antigens such as ESAT-6 and 
CFP-10 or even other new antigen combinations. In view of the above, the Commission asks the 
European Food Safety Authority to assess the available scientific data, including the reports provided 
by the Member States on the outcome of the EU co-finance eradication programmes, and issue a 
scientific opinion on the suitability of the IFN-γ test to be included by EU legislation as a prescribed 
test  for  bovine  TB  diagnosis,  to  be  used  as  an  alternative  to  the  tuberculin  skin  test  for  the 
establishment and maintenance of an officially tuberculosis free herd status and for certification for 
intra-Union trade in bovine animals.  
TERMS OF REFERENCE AS PROVIDED BY EUROPEAN COMMISSION 
The Commission asks the European Food Safety Authority: 
1. to issue a scientific opinion on the suitability of the IFN-γ test for inclusion amongst the official 
tests for the purpose of granting and retaining an officially tuberculosis free herd status as laid down 
in Annex A to Directive 64/432/EEC and certification for intra Union trade in bovine animals as 
required in Article 6(2)(a) of that Directive 
2. to issue a scientific opinion on the suitability of other, possibly newer, tests, if any, for their 
inclusion amongst the official tests for the purpose of granting and retaining an officially tuberculosis 
free herd status as laid down in Annex A to Directive 64/432/EEC and certification for intra-Union 
trade in bovine animals as required in Article 6(2)(a) of that Directive; bovine TB Test  
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3.  in  the  event  of  a  negative  opinion  to  point  (1),  to  advise  the  Commission  on  which  further 
validation studies are necessary to evaluate the suitability of the IFN-γ test, or any other new test, for 
inclusion amongst the official tests for the purpose of granting and retaining an officially tuberculosis 
free herd status as laid down in Annex A to Directive 64/432/EEC and certification for intra-Union 
trade  in  bovine  animals  as  required  in  Article  6(2)(a)  of  that  Directive.bovine TB Test  
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ASSESSMENT 
1.  Introduction 
Bovine TB is present in livestock and wildlife populations in a number of regions within the EU. 
According to EU Directive 64/432/EEC (“the Directive”), bovines can be moved from non-bovine 
TB-free regions to TB-free regions if they originate from herds that have been declared officially 
bovine-TB free and if the animals themselves have been tested bovine TB negative before transport. 
Testing needs to be done by an official test according to the Directive.  
Currently, the diagnostic assay known as the intradermal or skin test is the only official test in the EU 
for the purpose of granting and retaining official TB-free herd status, as laid down in Annex A to the 
Directive, and certification for intra-Union trade in bovine animals, as required in Article 6(2)(a) of 
the Directive. Two test procedures are recognised, the single intradermal test (SIT) using purified 
protein derivative (PPD) bovine tuberculin (a preparation obtained from the heat-treated products of 
Mycobacterium  bovis)  and  the  single  intradermal  comparative  cervical  test  (SICCT)  which  uses 
bovine  and  avian  PPDs  (avian  PPD  from  M.  avium).  Both  SIT  and  SICCT  are  performed  by 
intradermal injection of the PPDs, bovine at one site or bovine and avian at adjacent sites, on the neck 
of the animal and the interpretation is based on observing, measuring and recording 72 hours after 
inoculation the nature and extent of any increase in skin thickness at the bovine PPD injection site. In 
the comparative test (SICCT) this response is compared to that observed 72 hours after injection of 
avian PPD. When the standard interpretation of the tests is applied, inconclusive reactors
4 must be 
subjected to an additional skin test at least 42 days after the previous one; if they are not negative in 
the second test, they are deemed positive. However, to  maximise the sensitivity of the test a  severe 
interpretation may be a pplied (particularly in high -prevalence areas), in which all inconclusive 
reactors in the first skin test are considered positive and removed for slaughter (Anonymous, 2006).  
The skin test has a number of drawbacks, in terms of test characteristics, limit ed sensitivity at the 
level of the individual animal and testing logistics, as animals need to be examined on two occasions 
72  hours  apart.  Consequently, consideration is being given to the possibility of other tests, in 
particular the IFN-γ test, being included as official tests for the above-mentioned purpose.  
The  OIE  includes  the  skin  test  as  the  prescribed  test  for  international  trade  and  IFN-γ  as  the 
alternative test for international trade. This implies that the skin test is considered optimal and that 
IFN-γ can be used for international trade where there is mutual agreement between the importing and 
exporting country (OIE, 2012). 
The probability that the herd is truly free of bovine TB, given negative test results, is influenced by a 
range of factors, including the prior probability of freedom from TB, the herd size, the number of 
animals sampled, the minimum within-herd prevalence of bovine TB-infected animals to be detected 
(should the herd be infected) and the sensitivity of the test used. In the case of bovine TB, it is 
conceivable that only a single infected animal is present in a herd, for example where there is a 
programme to eliminate infected animals from the herd or where a herd was recently infected. At low 
within-herd prevalence, and using whole-herd testing (as is the case for granting  bovine-TB free 
status), the sensitivity of the test is the main determinant of the probability that a herd testing negative 
is  truly  free  of  bovine  TB.  For  this  reason,  this  opinion  principally  considers  the  diagnostic 
performance, particularly sensitivity, of tests for bovine TB in individual animals. Specificity is also 
                                                       
4  The interpretation of the skin test is based on the observation of clinical signs and on the increase in skin-fold thickness at 
the site of inoculation. A SIT is positive, inconclusive or negative when the increase is greater than 4 mm, between 2 mm 
and 4 mm or less than 2 mm, respectively; the SICCT is positive, inconclusive or negative when the bovine injection site 
exceeds the avian site by greater than 4 mm, 1–4 mm and less or 1 mm, respectively. bovine TB Test  
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considered because the rate of false-positive results is relevant with respect to retaining official TB-
free herd status. 
The current opinion does not include an assessment of the fitness, or lack thereof, of the diagnostic 
tests for the purpose of control and eradication. 
In this mandate, the first objective is to assess whether the IFN-γ test could be added to the official 
tests as a stand-alone test for demonstrating freedom from bovine TB  and  with respect to  intra-
Community trade (ToR 1). After discussion with the European Commission it was agreed that, in 
order  to  achieve  equivalence  (suitability)  as  a  stand-alone  test,  the  IFN-γ  test  should  meet  the 
following requirements: 
  have a sensitivity equivalent or superior to the standard test currently used in the EU, and  
  have a specificity not lower than that of the standard test with the lowest specificity currently 
used in the EU. 
Furthermore,  there  should  be  no  foreseeable  practical  difficulties  that  could  compromise  test 
performance.  
In addition, any other tests that meet the above requirements should be identified (ToR 2). In the 
event that no new test could be recommended, the additional objective was to inform the Commission 
of further studies required to evaluate the suitability of the IFN-γ test or any other new test (ToR 3). 
2.  Material and methods 
2.1.  Bovine TB diagnostic tests to be considered for evaluation 
A systematic literature review reported in 2011 identified a large number of tests available for the 
diagnosis of bovine TB (VLA, 2011). The ad hoc working group (WG) considered the list of tests and 
selected for evaluation the tests included in Table 1. The tests were selected based on their suitability 
for use in large-scale surveys of live animals and the information available for their evaluation. They 
are described in Appendix B as well as the skin tests and the post-mortem tests currently used in the 
EU. The tests that were excluded and the reasons for exclusion are reported in Appendix A. 
Table 1:   Diagnostic tests for bovine TB considered for evaluation in this opinion  
Test name
(a)  Abbreviation  Long description 
PPD-based IFN-γ 
IFN-γ bovine–avian  IFN-γ-BA  Gamma interferon test with bovine PPD and avian PPD diagnostic 
antigens 
IFN-γ bovine  IFN-γ-B  Gamma interferon test with bovine PPD diagnostic antigen 
Defined antigens-based IFN-γ 
IFN-γ CFP10 ESAT6  IFN-γ-CE  Gamma interferon test with CFP10 and ESAT6 diagnostic antigens 
IFN-γ MPB70  IFN-γ-MPB  Gamma interferon test with MPB70 diagnostic antigen 
IFN-γ BACE  IFN-γ-BACE  Gamma interferon test with bovine PPD and avian PPD diagnostic 
antigens and CFP10 and ESAT6 diagnostic antigens 
Antibody detection tests 
ELISA bovine–avian  ELISA-BA  Enzyme-linked immunosorbent assay with bovine PPD and avian 
PPD diagnostic antigens 
ELISA bovine  ELISA-B  Enzyme-linked immunosorbent assay with bovine PPD diagnostic 
antigen 
ELISA MPB70  ELISA-MPB  Enzyme-linked  immunosorbent  assay  with  MPB70  diagnostic 
antigen bovine TB Test  
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Multiplex 
immunoassay 
Multiplex  Enzyme-linked immunosorbent assay based on the use of multiple 
mycobacterial antigens  
Latex  bead 
agglutination assay  
LBBA  Latex bead agglutination assay using defined antigens (ESAT-6 and 
MPB70) 
Serological rapid   Rapid  Rapid  immunochromatographic  assay  using  defined  antigens 
(MPB83, CFP10/ESAT-6) 
(a)  The tests have been classified regarding the mechanism of detection test and their antigen composition. It is important 
to notice that different cut-off values are used for the interpretation of the test results. Currently the IFN-γ assay kit 
(different  antigens  can  be  used  with  the  same  basic  test  kit)  the  serological  rapid  test  (Rapid)  and  the  multiplex 
immunoassay (Multiplex) are commercially available. 
2.2.  Data sources 
Data sources used for this opinion were: (1) a systematic literature review and meta-analysis carried 
out by the Animal Health and Veterinary Laboratories Agency
5 (AHVLA) together with scientists and 
veterinarians from other research groups and government agencies (Downs et al., 2011; VLA, 2011); 
(2) new publications about diagnostic test performance that had  become available since the original 
searches for the AHVLA review; and (3) data from a public data call.  
Reports  provided  by  the  Member  States  on  the  outcome  of  the  EU  co -financed  eradication 
programmes  were evaluated as a pos sible data source but  were not helpful in responding to   the 
mandate  owing  to  a  lack of detail on important variables such as test procedures or  number of 
available tests (see Section 2.3 and Appendix E for data requirements). 
2.2.1.  Systematic literature review 
A systematic review of the literature and meta-analysis of the performance of diagnostic tests for 
bovine TB in cattle was reported in 2011 (Downs et al., 2011; VLA, 2011). This review comprised 
comprehensive searches of the peer-reviewed and grey literature for relevant studies and a structured 
approach to the assessment and extraction of data relating to diagnostic test performance. Further 
details about the methodology of the systematic review of relevant literature and subsequent meta-
analysis can be found in Appendix C and the full report (VLA, 2011).  
It was agreed that the findings from the AHVLA review should be considered within the response to 
the mandate. However, for this mandate we considered only studies that comprised the diagnostic 
tests included in Table 1 and studies in which at least two diagnostic tests (one of which could be used 
as a reference standard) were used, whereas studies were eligible for the evaluation of specificity in 
the AHVLA review in which a test was evaluated in a bovine TB-free population, even if another 
diagnostic test had not been used as a reference standard. 
2.2.2.  Update from the literature review 
Searches were conducted to identify any new data on diagnostic test performance that had become 
available since the original searches for the AHVLA review. Relevant new results were considered 
within  the  response  to  the  mandate  but  were  not  incorporated  in  the  meta-analysis  previously 
performed. 
The  search  of  electronic  databases  for  the  AHVLA  systematic  review  was  last  performed  on  1 
December 2008. The update was conducted by EFSA on 13 March 2012 using the same search string 
without language restrictions on Web of Knowledge (which simultaneously searches Web of Science 
1995–, Current contents 1998–, CAB abstracts 1910–, MEDLINE 1950–). Details of the searches and 
the methodology of the review are presented in the Appendix D. 
                                                       
5  Formerly known as the Veterinary Laboratories Agency (VLA).  bovine TB Test  
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2.2.3.  Public data call 
To maximise the amount of information available on bovine TB tests, EFSA launched a public data 
call (Appendix E). Criteria for inclusion or exclusion of data were set. The call was open from 26 
March to 26 April 2012. A summary of all received datasets and relevant variables for its evaluation 
is included in Table 8, Appendix F. 
2.3.  Analysis of data from public data call 
Data from the public data call were analysed by a Bayesian latent class model that enables estimation 
of sensitivity and specificity in the absence of information on the true bovine TB status of an animal 
(Toft  et  al.,  2005).  The  model  parameters  estimated  were:  (1)  the  prevalence  in  the  populations 
(datasets)  considered;  (2)  the  sensitivity  and  specificity  of  the  various  tests  in  the  different 
populations; and (3) conditional dependence between tests. At a minimum, latent class analysis using 
results from two tests requires data from two populations with varying prevalence. Unfortunately, 
owing to the variability of the test protocols (differences in antigen used and cut off-values) it was not 
possible to combine datasets originating from different countries. This meant that data from a single 
population  sent  in  response  to  the  call  could  only  be  included  if  at  least  three  test  results  were 
available from the population.  
The datasets that met these criteria are summarised in Table 2 and they all refer to testing with IFN-γ-
BA. Tuberculin skin test (either SIT or SICCT) and different post-mortem tests were used as second 
and third tests. 
Only for the Northern Ireland data sets (ID 3 to 9) were post-mortem results available for all animals 
in the datasets. For the other studies post-mortem results were missing for animals that were negative 
for both the IFN-γ and skin test and on some occasions for animals in which both tests were positive 
or the IFN-γ test was positive and the skin test negative.  
Three different scenarios were considered to simulate the missing data: 
-  Scenario  I:  The  post-mortem  result  is  98 %  negative  when  the  IFN-γ  and  skin  test  are 
negative. The proportions observed in the available data are maintained for the cases when 
both tests are positive or the IFN-γ test is positive (Table 11, Appendix G). The WG members 
considered this as the most likely scenario. 
-  Scenario II: The post-mortem result is in agreement with the IFN-γ test result. 
Scenario III: The post-mortem result is in agreement with the skin test result. 
The outcomes of the IFN-γ and skin test were considered to be dependent because they both target the 
cell-mediated immune response, whereas the post-mortem result was assumed to be conditionally 
independent. In the Bayesian modelling non-informative priors were used. In order to assess the 
model fit, the predicted frequencies for each of the combination of results for the three tests and the 
observed frequencies were plotted. The convergence diagnostic proposed by  Brooks and Gelman 
(1998) was used, indicating that convergence was reached in all models. Details of the model are 
presented in Appendix G. 
   bovine TB Test  
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Table 2:   Datasets originating from the public call for data included in the analysis 
ID    Year   Country  Cut-off for IFN-γ-BA
(a)  Skin 
test
(b)  Post mortem  N
(c) 
1 
Raw  data 
CAM  2010-
2011.xlsx 
2010  Spain  PPDbOD – NILOD > 0.05 
and PPDbOD > PPDaOD 
SICCT 
severe  Culture  2 449 
2 
Raw  data 
CAM  2010-
2011.xlsx 
2011  Spain  PPDbOD – NILOD > 0.05 
and PPDbOD > PPDaOD 
SICCT 
severe 
Culture  or 
macroscopic 
lesions 
3 690 
3 
Prob_Net_IFNg 
2004  Northern 
Ireland 
PPDbOD – NILOD   0.1 
and  PPDbOD –
 PPDaOD   0.05 
SICCT 
standard 
Culture  or 
macroscopic 
lesions 
367 
4 
Prob_Net_IFNg 
2005  Northern 
Ireland 
PPDbOD – NILOD   0.1 
and  PPDbOD –
 PPDaOD   0.05 
SICCT 
standard 
Culture  or 
macroscopic 
lesions 
1 653 
5 
Prob_Net_IFNg 
2006  Northern 
Ireland 
PPDbOD – NILOD   0.1 
and  PPDbOD –
 PPDaOD   0.05 
SICCT 
standard 
Culture  or 
macroscopic 
lesions 
905 
6 
Prob_Net_IFNg 
2007  Northern 
Ireland 
PPDbOD – NILOD   0.1 
and  PPDbOD –
 PPDaOD   0.05 
SICCT 
standard 
Culture  or 
macroscopic 
lesions 
625 
7 
Prob_Net_IFNg 
2008  Northern 
Ireland 
PPDbOD – NILOD   0.1 
and  PPDbOD –
 PPDaOD   0.05 
SICCT 
standard 
Culture  or 
macroscopic 
lesions 
1 304 
8 
Prob_Net_IFNg 
2009  Northern 
Ireland 
PPDbOD – NILOD   0.1 
and  PPDbOD –
 PPDaOD   0.05 
SICCT 
standard 
Culture  or 
macroscopic 
lesions 
1 469 
9 
Prob_Net_IFNg 
2010  Northern 
Ireland 
PPDbOD – NILOD   0.1 
and  PPDbOD –
 PPDaOD   0.05 
SICCT 
standard 
Culture  or 
macroscopic 
lesions 
1 516 
10 
Raw  data 
CAM  2010-
2011.xlsx 
2010  Spain  PPDbOD – NILOD > 0.05 
and PPDbOD > PPDaOD 
SIT 
severe  Culture  3 649 
11 
Raw  data 
CAM  2010-
2011.xlsx 
2011  Spain  PPDbOD – NILOD > 0.05 
and PPDbOD – PPDaOD 
SIT 
severe 
Culture  or 
macroscopic 
lesions 
3 873 
12 
120326ax1_Irel
and(GormleyE)
_TC_1st 
August2012.xls
x 
2008  Ireland 
PPDbOD > 0.1,  PPDbOD –
 NILOD > 0.05  and 
PPDbOD > PPDaOD 
SICCT 
standard 
Macroscopic 
lesions  2 740 
13 
120326ax1_Irel
and(GormleyE)
_TC_1st 
August2012.xls
x 
2008  Ireland 
PPDbO > 0.1,  PPDbOD –
 NILOD > 0.05  and 
PPDbOD > PPDaOD 
SICCT 
standard 
Macroscopic 
lesions  2 197 
(a)  Cut off values for interpretation of IFN-γ-BA, the different optical density (OD) readings obtained after the stimulation 
with each antigen (bovine PPD/avian PPD/PBS) are used to yield a quantitative result: OD obtained after stimulation 
with PBS (NILOD) is often subtracted from the OD observed after stimulation with bovine PPD (PPDbOD) and avian 
PPD (PPDaOD). 
(b)  Skin  test  type  and  interpretation:  severe  interpretation  in  which  all  inconclusive  reactors in  the  first  skin  test  are 
considered as positive; and standard in which inconclusive reactors are retested.  
(c)  Number of records (individual animals). bovine TB Test  
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3.  Results 
3.1.  Systematic literature review and meta-analysis 
The performance of the diagnostic tests identified by EFSA as relevant to the mandate that were also 
estimated in the meta-analysis, conducted by AHVLA and others, is summarised below and in Table 
3. Further results can be found in the full report (VLA, 2011).  
Estimates of the sensitivity of the diagnostic tests from the meta-analysis had wide credible intervals.
6 
In general the credible intervals were narrower for the IFN-γ tests than for the skin test, but there was 
considerable overlap of the credible intervals between test-types. The sensitivities of IFN-γ-B, IFN-γ-
BA and IFN-γ-CE were not significantly different from the sensitivities of SIT and SICCT. IFN-γ 
using MPB70 had significantly lower sensitivity than both skin tests. 
Although the sensitivity of the ELISA tests were also not significantly different from those of the skin 
tests, the credible intervals were wider than those of the IFN-γ and skin tests, indicating that the 
variability of the sensitivity across studies is very high. The median sensitivity of the LBBA (0.91) 
was  among  the  highest  of  all  the  tests  and  the  distribution  of  the  credible  interval  was  narrow; 
however, this was based on the results of only two studies from one research group. There were no 
eligible data with which to estimate the sensitivity of the rapid test.  
The SICCT test at standard interpretation had the highest median specificity of all the diagnostic tests 
under evaluation and its specificity was significantly higher than that of all the IFN-γ tests except 
IFN-γ-CE. The median specificity of SIT was lower than that of SICCT and the IFN-γ tests, but the 
credible interval of SIT was wide and overlapped with those of the other tests.  
Specificity distributions for the ELISA tests were wider than those estimated for the IFN-γ tests and 
the SICCT, and the median estimates were slightly lower. The estimates for the specificity of both the 
LBBA and the rapid test had wide credible intervals, and the median specificities were lower than 
those for SICCT test. 
Estimates of sensitivity and specificity were weighted in the modelling procedure to account for the 
varying number of estimates within references for the same test type and population. Adjustment was 
made for confounding factors and a random effect term was incorporated to account for clustering of 
errors  within  references  (see  Appendix  C  and  VLA,  2011  for  further  detail).
                                                       
6  A 95% Bayesian credible interval states that the estimated probability that the process used to generate the interval 
includes the correct value of the parameter is 95%. bovine TB Test  
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Table 3:   Summary of meta-analysis results for sensitivity and specificity of diagnostic tests for bovine TB on cattle from AHVLA systematic 
review (VLA, 2011) 
Test Name  Sensitivity   Specificity 
Reference 
(a) 
Estimates
(b)  Overall adjusted estimate 
(c)  
References 
(a) 
Estimates
(b)  Overall adjusted estimate 
(c) 
N  n  P025
  Median  P975  N  n  P025
  Median  P975 
Skin test 
SIT (cervical)  7  16  0.49  0.94  1.00  4  10  0.70  0.91  1.00 
SICCT severe
(d)  25  57  0.37  0.61  0.82  0  0       
SICCT standard
(e)  25  57  0.27  0.49  0.74  7  13  0.99  1.00  1.00 
PPD-based IFN-γ  
IFN-γ-B
(e)  27  166  0.72  0.87  0.95  19  137  0.94  0.97  0.98 
IFN-γ-BA
(e)  27  166  0.49  0.67  0.82  19  137  0.96  0.98  0.99 
Defined antigen-based IFN-γ 
IFN-γ-CE
(e)   27  166  0.61  0.79  0.91  19  137  0.99  0.99  1.00 
MPB70
(e)   27  166  0.04  0.1  0.25  19  137  0.85  0.94  0.98 
Antibody detection tests 
ELISA-B-PPD
(e)  22  59  0.06  0.76  0.99  12  27  0.80  0.90  0.95 
ELISA-B-PPD-A-PPD
(e)  22  59  0.01  0.36  0.97  12  27  0.82  0.93  0.98 
ELISA-MPB
(e)   22  59  0.01  0.20  0.94  0  0       
LBBA  2  3  0.60  0.91  0.98  1  1  0.39  0.94  1.00 
Multiplex   1  5  0.31  0.74  0.95  1  4  0.34  0.88  0.99 
Rapid  0  0        2  3  0.66  0.97  1.00 
Post mortem 
Meat inspection  6  11  0.38  0.71  0.92  1  3  0.99  1.00  1.00 
Detailed necroscopy in laboratory
(f)  6  11  0.82  0.96  1.00  0  0       
Culture of M. bovis  8  16  0.46  0.74  0.94  1  1  0.73  0.99  1.00 
(a) 
 The number of references with at least one estimate of either sensitivity or specificity. 
(b)  The number of estimates used in the modelling of sensitivity or specificity. This does not equal the number of references because a reference could contain more than one 
estimate. 
(c)  Median and Bayesian 95 % credible interval. 
(d)  Severe interpretation in GB: Reaction to bovine tuberculin is positive and the reaction to avian tuberculin is negative or animals show a positive bovine reaction more than 2 mm 
greater than a positive avian reaction.  
(e)  Standard interpretation in GB: Reaction to bovine tuberculin is both positive and exceeds the reaction to avian tuberculin by more than 4 mm.  
(f)  Includes inspection for macroscopic lesions typical of M. bovis infection but does not include microscopic examination. bovine TB Test  
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3.2.  Updated literature review 
The update to the literature review identified 938 research studies published up to March 2012 that 
had not been included in the systematic literature review (VLA, 2011). After relevance screening, a 
total of 15 studies was reviewed in order to collect information regarding sensitivity and specificity of 
bovine TB tests (Table 7, Appendix D). As limited resources did not permit a new meta-analysis 
including all identified studies (Sections 3.1 and 3.2), it was decided to present only a description of 
the results reported in the relevant studies.  
Sensitivity  estimates  of  IFN-γ-BA  were  in  line  with  the  estimates  from  the  systematic  literature 
review (Alvarez et al., 2009; Clegg et al., 2011) or higher (with point estimates > 0.82 but overlapping 
confidence intervals: Marassi et al., 2011; Antognoli et al., 2011; Faye et al., 2011; Alvarez et al., 
2012). The specificity values were in general lower, with a strong influence of the cut-off value in 
place in each of the studies. The only study reporting values of IFN-γ with other antigens (ESAT6-
CFP10) yielded estimates for both sensitivity and specificity similar to those of the IFN-γ-BA (Faye et 
al., 2011)  
Multiplex assays had high sensitivity values when performed on animals with gross pathology typical 
of bovine TB (Whelan et al., 2010, 2011), but showed a more limited ability to detect infected animals 
when estimated using a latent class analysis (0.34–0.72, depending on the cut-off value used (Clegg et 
al., 2011), which was in agreement with what was obtained in the systematic literature review.  
Sensitivity values obtained with other serological techniques (ELISA and lateral flow assays using 
different antigens from members of the M. tuberculosis complex) were in agreement with estimates 
provided  by  the  systematic  literature  review.  A  large  variation  was  observed  in  the  sensitivity 
estimates reported (median estimates being from a minimum value of 0.344 up to a maximum value 
of 0.879), which was related to the different antigens/cut-off/comparator test used in each of the 
studies. When available, specificity estimates of antibody assays were equivalent to or higher than 
those found in the systematic literature review, although in the case of the Multiplex these were highly 
influenced by the cut-off value used.  
3.3.  Analysis of data from public data call  
The estimates of the sensitivity and specificity of IFN-γ-BA from the Bayesian latent class analysis 
are summarised in Table 4. Sensitivity, specificity, covariance and the agreement measure (kappa) for 
all countries (Scenario I) are shown in Figures 3–10 in Appendix G. 
The lower limits of the credible intervals for the sensitivity of IFN-γ-BA, taking Scenario I for the 
Irish and Spanish data, were higher than the upper limits of the credible intervals for SIT and SICCT, 
indicating  that  IFN-γ-BA  had  a  significantly  higher  sensitivity.  The  upper  limits  of  the  credible 
intervals of the specificity of IFN-γ-BA were consistently lower than the lower limits of the credible 
intervals for SIT and SICCT, indicating significantly lower specificity. The differences between the 
IFN-γ-BA sensitivity estimates from different countries were limited. For specificity, however, the 
credible interval of the estimates obtained from the Northern Ireland dataset were markedly lower. 
The estimates resulting from the Spanish data show low sensitivity for SIT and SICCT in comparison 
with Northern Ireland and Ireland and similar specificity estimates for SIT and SICCT.  
Scenarios II and III showed similar results to Scenario I regarding the comparison of IFN-γ and skin 
tests, indicating that the influence of missing post-mortem data is of minor importance. Only when 
applying Scenario II to the Irish data did the credible intervals for the specificity of IFN-γ-BA and the 
skin test grossly overlap, indicating a non-significant difference. Conditional dependency between 
IFN-γ-BA and the skin test was low.  
In the datasets the largest estimated prevalence was approximately 0.4 (0.3707 – 0.4240) and the 
lowest 0.0034 (0.0005 – 0.0085). bovine TB Test  
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Table 4:   95 % Credible intervals (upper and lower limits) for sensitivity, specificity and conditional dependency as obtained by Bayesian latent class 
analysis 
ID  Sensitivity  Specificity  Conditional dependency between 
IFN-γ-BA and skin test 
IFN-γ-BA  Skin test  Post mortem  IFN-γ-BA  Skin test  Post mortem  Infected class  Non-infected 
class 
3 to 9  Northern 
Ireland  
SICCT 
standard 
  0.885; 0.936  0.525; 0.608  0.543; 0.632  0.661; 0.691  0.964; 0.975  0.988; 0.997  –0.034; –0.009  –0.010; –0.005 
1-2  Spain 
SICCT 
Severe 
Scenario I 
Most likely 
0.864; 0.998  0.298; 0.426  0.620; 0.871  0.918; 0.941  0.988; 0.996  0.977; 0.987  –0.009; 0.036  –0.0003; 0.005 
Scenario II 
IFN-γ and post-
mortem 
agreement 
0.978; 0.998  0.278; 0.379  0.761; 0.995  0.925; 0.948  0.988; 0.996  0.9993; 1  –0.011; 0.0002  -0.0002; 0.005 
Scenario III 
Skin  and  post-
mortem 
agreement 
0.976; 0.997  0.287; 0.383  0.761; 0.99  0.938; 0.956  0.987; 0.994  0.9995; 1  –0.013; 0.000  0.00; 0.006 
10-11  Spain  
SIT 
Severe 
Scenario I  0.765; 0.996  0.304; 0.460  0.665; 0.981  0.926; 0.947  0.986; 0.995  0.977; 0.992  –0.009; 0.065  0.00; 0.006 
Scenario II  0.976; 0.997  0.287; 0.383  0.761; 0.995  0.938; 0.956  0.987; 0.994  0.9995; 1  –0.013; 0.000  0.00; 0.006 
Scenario III  0.967; 0.996  0.405; 0.525  0.720; 0.988  0.925; 0.941  0.988; 0.995  0.9995; 1  –0.014; 0.001  –0.003; 0.005 
12-13  Ireland 
SICCT 
standard 
Scenario I  0.791; 0.861  0.645; 0.730  0.359; 0.423  0.882; 0.908  0.993; 0.9996  0.974; 0.985  –0.041; 0.0003  0.000; 0.002 
Scenario II  0.846; 0.889  0.480; 0.532  0.438; 0.489  0.996; 1  0.997; 1  0.995; 1  –0.045; –0.024  0.0001; 0.006 
Scenario III  0.788; 0.845  0.651; 0.730  0.351; 0.417  0.878; 0.905  0.993; 0.9996  0.995; 0.9991  –0.030; 0.00  0.0001; 0.005 
 bovine TB Test  
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4.  Discussion 
4.1.   Systematic literature review  
The results indicate that the IFN-γ test, as used in the eligible studies, had a sensitivity similar 
to or higher than the most comparable skin tests. Moreover, although the specificities of the 
IFN-γ  test,  apart  from  IFN-γ-CE,  were  lower  than  that  of  the  SICCT  test,  the  median 
estimates for the IFN-γ test were higher than the median estimates for the specificity of the 
SIT and the estimates were not statistically significantly different.  
Setting  aside  the  results  of  the  IFN-γ  test using  MPB70,  there  was no  evidence  that the 
performance of the ELISA tests could match that of the IFN-γ test. The estimate for the 
sensitivity of LBBA was comparable to those for the skin tests and the IFN-γ tests but the 
data for this test were derived from only two studies. 
The wide credible intervals, particularly for the sensitivity estimates, were due to relatively 
few studies with eligible data, heterogeneity as a result of the variety of cut-off values used to 
classify a positive response in the blood tests (despite the use of a counter-parameter) and the 
influence  of  covariates  that  were  controlled  for  within  the  analysis.  At  the  outset  of  the 
systematic  review  a  range  of  potentially  influential  factors  was  identified  because  it  was 
recognised that test performance may vary in different subgroups such as calves and adult 
cattle,  dairy  cattle  and  other  cattle.  Information,  if  available,  about  potentially  influential 
confounding factors such as country of study, year of study, sampling strategy, possible cross-
reactivity with environmental mycobacteria, type of animal production system and type of 
reference standard was extracted from the eligible references in addition to test performance 
data. 
Inclusion  criteria  for  the  review  required  that  all  the  studies  from  which  sensitivity  was 
estimated were from cattle populations naturally exposed to M. bovis, and all the studies from 
which specificity was estimated were from cattle populations reported as officially TB free or 
reported as free and having been free for several years. This meant that the  estimates of 
sensitivity and specificity were derived from different populations. Furthermore, the estimates 
of sensitivity relative to the reference test used to classify an animal as truly infected would 
have been influenced by the accuracy of the reference test and the stage of the disease in the 
population sample. The probability of misclassification should be lower in the estimation of 
specificity because the populations on which specificity was measured were selected to be 
exposure and infection free.  
4.2.  Updated literature review 
The existing differences in the protocols used in the performance of the IFN-γ-BA complicate 
the joint interpretation of the results of the studies reviewed. The effect of the different cut-off 
values,  as  well  as  other  differences  in  the  protocols  used  in  each  study  (different  gold 
standards, collection of blood samples for the assay 3–10 days after a SICCT test), may 
explain  the  width  of  the  confidence  intervals  reported.  The  variability  in  the  specificity, 
ranging from 0.8484 to 0.99, is most likely also affected by the cut-off value applied.  
The  use  of  defined  antigens  (CFP10-ESAT6)  provided  high  sensitivity  and  specificity, 
comparable to the specificity estimates obtained for IFN-γ-BA.  
Information  on  the  performance  of  the  serological  assays  (multiplex,  ELISAs  detecting 
antibodies elicited against MPB70–83, MPT-51, Ag85 and BCG antigens and the lateral flow 
assay) was available for samples from two different origins. When performed on samples 
from animals with macroscopic lesions (and often following isolation of M. bovis), consistent 
with bovine TB, i.e., those animals most likely to be in a progressive stage of infection, or bovine TB Test  
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when the skin test was the only reference test used to define an animal as a true positive, 
serological assays were able to detect a large proportion of infected animals (> 80 %) when 
the most sensitive cut-off values were applied. However, all serological tests showed lower 
sensitivities when a larger sample population was analysed (including animals from which M. 
bovis was isolated but did not present macroscopic lesions). The latter results may provide a 
more accurate representation of the potential usefulness of these tests when they are used in 
populations  subjected  to  eradication  programmes  in  which  a  large  proportion  of  infected 
animals would be in the early stages of infection.  
4.3.  Analysis of data from public data call 
The results for the different datasets and scenarios show that IFN-γ-BA had higher sensitivity 
and lower specificity than the skin test. Although the trend is consistent with the results of the 
systematic literature review, the specificity of IFN-γ-BA was lower here than in the AHVLA 
literature review, which may (besides differences in the way the tests were performed and 
interpreted) be explained by the different populations.  
The  population  sampling  strategy  and  prevalence  of  bovine  TB  and  other  environmental 
mycobacteria in the herd can influence measured test performance (Aagaard et al., 2010; 
Farnham  et  al.,  2012)  and  has  implications  for  the  extrapolation  of  the  results  to  other 
populations. In the meta-analysis specificity was estimated entirely from cattle populations 
which the authors of the studies had reported as officially TB free or free from infection for 
several  years.  This  inclusion  requirement  is  likely  to  have  reduced  the  probability  of 
misclassification of truly infection free cattle. By comparison, the test performance from the 
data call was estimated from populations in which bovine TB was endemic and was based on 
comparisons across diagnostic tests of varying accuracy. In addition, the results reported from 
the meta-analysis were adjusted for a census-based or random population sampling strategy 
and absence of cross-reactivity with other mycobacteria, based on information available from 
the reviewed papers. The selection of the cattle populations, the bovine TB testing history of 
the cattle and the prevalence of environmental mycobacteria (that may infect cattle and elicit 
responses to PPD), may have influenced performance estimates in the surveillance population 
samples used in the latent class analysis.  
The estimates for specificity obtained from the Northern Ireland dataset are lower that the 
ones obtained from other datasets. These results are a reflection of the large proportion of 
positive IFN-γ test results in which both skin test and post-mortem results were negative. The 
datasets were validated by the data provider and all model checks made, including a test on 
the possible effect of mixing results from different years. It is difficult to explain because the 
cut-off values used in Northern Ireland should not have resulted in lower specificity when 
compared with the results from Ireland where less specific cut-off values are used. Possible 
explanations for the observed results may be technical issues on the execution of the test 
(such as time of blood collection) and differences in the cohorts of animals under testing. 
The probability that a bovine TB-infected animal is detected will, to a large extent, depend on 
the stage of the infection, and this applies to all the available bovine TB tests as they target 
different subpopulations of infected animals, not always overlapping (Pollock et al., 2005). 
The distribution of this probability across the various infection stages is different for the 
various  tests.  When  test-positive  animals  are  being  removed  from  a  population,  the 
distribution of infected animals across the different infection stages will change and, with 
that, the sensitivity of the test. This may explain the low sensitivity of the skin test in the 
Spanish dataset. In these herds the skin test had been performed frequently and, consequently, 
most of the skin test reactors might have already been removed in previous tests and most of 
the infected animals remaining in the herds would be in the early stages of infection, when the 
skin test is known to have more limited sensitivity (Monaghan et al., 1994). Interestingly, 
specificities of the SIT (Spain) and the SICCT (all three countries) were very similar. In Spain bovine TB Test  
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this  could  likely  be  due  to  a  lack  of  cross-sensitization  of  cattle  by  environmental  non-
tuberculous mycobacteria, which is measured by the response to injection with avian PPD. A 
low level of cross-sensitization will limit the difference in the test specificity between the SIT 
and SICCT. In Ireland and the UK, where cross-sensitization is relatively high, the SICCT is 
routinely used in order to maintain the high specificity of the test, while this test is only used 
in Spain in OTF herds in which a possible bovine TB infection has been excluded by post-
mortem analysis and epidemiological evidence. 
The low conditional dependency between the IFN-γ and skin test suggests that, although both 
tests  detect  a  cell-mediated  immune  response  (Pollock  et  al.,  2005),  they  target  different 
subpopulations of sensitised lymphocytes (Neill et al., 1994, Pollock et al., 2005, Gormley et 
al., 2006). Consequently, using both tests in combination is expected to increase sensitivity 
(parallel use) or specificity (serial use). Serial use (whereby positive test results are confirmed 
by a second test) is of interest for the purpose of this mandate. As an example, if we take the 
median test characteristics of IFN-γ-B and SIT shown in Table 3 and assume conditionally 
independent serial testing, specificity is as high as 0.997, whereas sensitivity is 0.818 (higher 
than the median estimates of the sensitivity of SICCT or IFN-γ-BA).  
4.4.  Negative predictive value  
When importing animals from a bovine TB-infected region, the negative predictive value 
(NPV) is of primary importance for the importing country. The NPV) is the probability that a 
test-negative animal is free from bovine TB. The NPV depends on the accuracy of the test and 
the prevalence of infected animals in the population. Figure 1(a) and (b) show the NPV for an 
individual animal testing negative for a prevalence ranging from 0.0 to 0.04 and using the 
sensitivity and specificity (excluding the value from Northern Ireland) ranges for skin tests 
and the IFN-γ test shown in Table 4. In the case of a negative test result, and assuming the 
same prevalence, one can be more certain of having a bovine TB-free animal when using the 
IFN-γ test than when the skin test is used. In cases in which more animals are being tested, the 
probability that at least one of them is positive also increases (Figure 1(c)–(f), although to a 
lesser extent with the IFN-γ test than with the skin test.  
   bovine TB Test  
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Single animal tested 
IFN-γ-BA test  
(specificity of 0.85, 0.90, 0.95, 0.99, 0.995) 
Skin test  
(specificity of 0.98, 0.99, 0.995) 
   
100 animals tested 
   
1 000 animals tested 
   
Figure 1:   IFN-γ and skin test NPVs when a single animal (a, b), 100 animals (c, d) and 
1 000 animals (e, f) are tested. The specificity is represented by layers in the plane. bovine TB Test  
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4.5.  Probability that a truly bovine TB-free herd will be classified as TB free 
For a herd to be granted bovine TB-free status, all animals will need to test negative during 
repeated herd tests. Figure 2 shows the probability that all animals in a herd will test negative, 
given that they are free of bovine TB. At the specificity estimates shown in Table 4, the 
probability that a herd will not have a single positive result decreases sharply as herd size 
increases. When the specificity of the test is 98 % (median estimate from the AHVLA for 
IFN-γ-BA), there is only a 13.3 % probability in a 100-animal herd that all animals will test 
negative. 
 
Figure 2:   Probability, within a bovine TB-free herd, that all animals will test negative 
for the number of animals tested and test specificity ranging from 0.850 to 0.995. 
4.6.  Practical issues in the application of the IFN-γ test 
The  application  of  the  IFN-γ  assay  to  detect  M.  bovis  infection  in  cattle  offers  several 
practical advantages over the skin test. The problems associated with skin testing of animals, 
including poor facilities, poorly calibrated equipment and the potential for fraud, are reduced 
when performing the blood-based test. In addition, as it does not require a second farm visit to 
read the test, this can have a beneficial impact on workload, the safety of personnel and the 
welfare of animals through reduced handling and minimising stress levels. The IFN-γ assay 
can be repeated in the laboratory and good laboratory practice (GLP) can readily be applied to 
ensure accuracy and reliability. In infected herds (containing reactors already disclosed by 
tuberculin tests) the test can be applied in different ways, depending on the suspected level of 
infection in the herd.  
The test is robust and relatively easy to standardise across different laboratories. The adoption 
of interpretation criteria based on quantitative values allows for more objective interpretation 
of the results in contrast to the more subjective interpretation of skin test results. Another 
advantage of the assay procedure used is that the interpretation criteria can be adjusted to take 
account of local conditions; this can serve to maximise the detection of infected animals 
depending on the prevailing circumstances (e.g., in low-incidence areas the interpretation can 
be adapted to maximise the specificity of the test). The test also allows the incorporation of bovine TB Test  
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defined antigens to enhance the specificity of the test (Buddle et al., 2001, 2003; Waters et al., 
2004;  Schiller  et  al.,  2010a).  Towards  the  completion  of  an  eradication  campaign,  the 
interpretation can be adjusted to optimise the specificity of the test. 
There are, however, some disadvantages to the use of the IFN-γ assay. Each of the two stages 
of  the  test  requires  specific  equipment.  As  a  result,  there  can  be  significant  set-up  costs 
involved in carrying out IFN-γ diagnostic tests to GLP standards. In the first stage of the test, 
the time between collection of the samples and their processing (overnight incubation with 
antigens) in the laboratory differs between countries and can range from less than 8 hours up 
to 24 hours post collection, depending on the use to which the test is being put. This can lead 
to a decrease in the test signal, increasing its specificity but also compromising its sensitivity 
under certain conditions (Gormley et al., 2004; Coad et al., 2007; Waters et al., 2007; Schiller 
et  al.,  2009).  Tuberculin  potency  may  be  different  and  relevant  differences  may  lead  to 
difficulties in comparing the sensitivity/specificity of the test across countries (Whipple et al., 
2001; Gormley et al., 2006; Schiller et al., 2010b). When a laboratory is fully equipped, the 
running costs are primarily associated with the consumables required to perform the test, 
equipment maintenance/servicing and personnel time. The high costs involved may be offset, 
however, by the fact that there is no need to visit the farm on more than one occasion. As all 
EU  Member  States  possess  the  basic  necessary  infrastructure  required  to  conduct  IFN-γ 
diagnostic  assays,  there  are  few,  if  any,  impediments  to  conducting  IFN-γ  tests  to  GLP 
standards. 
Because of the varied and complex nature of the immune response of cattle to infection with 
M. bovis and the fact that M. bovis-infected cattle are being detected at a much earlier stage of 
the  disease  than  formerly,  some  difficulties  in  diagnosis  can  be  expected  to  arise  with 
laboratory-based tests. One factor that might influence the performance of the IFN-γ test is 
the effect of a prior tuberculin test. Blood for analysis may be collected from animals prior to 
skin testing or after the skin test is performed (usually the day the test is read, 72 hours after 
intradermal inoculation of PPDs). This can have an immune modulator effect in terms of the 
specific  IFN-γ  release  that  may  be  reflected  in  the  test  outcome  (Whipple  et  al.,  2001; 
Gormley et al., 2004; Whelan et al., 2004; Schiller et al., 2010c).  
4.7.  Further validation studies on the IFN-γ test 
IFN-γ  has  predominantly been  used  as  an ancillary  test  to  increase the  sensitivity  of the 
testing protocol in order to eliminate infected animals from herds and obtain TB-free herd 
status.  Consequently,  there  has  been  limited  use  of  the  test  as  a  stand-alone  test  for  the 
purpose of granting or retaining TB-free status. Nevertheless, data used to estimate specificity 
in the AHVLA study originated from bovine TB-free regions, indicating that the estimates are 
valid in that situation. In the AHVLA systematic literature review the specificity estimate of 
IFN-γ-BA is based on results from 19 different studies, and the credible intervals on the 
estimates are narrow. It seems  that little would be gained from further  similar  validation 
studies.  
Studying critical factors that may affect the specificity of IFN-γ in different situations could 
be useful, given the variation in test performance observed in the surveillance populations and 
the indication of differences in test performance between PPD-based antigens and defined 
antigens  such  as  ESAT6  CFP10.  Specificity  may  differ  from  one  region  to  another,  for 
example owing to differences in the distribution of environmental mycobacteria and between 
cattle populations.  
To optimise use of the IFN-γ test in bovine TB-free populations, an optimal cut-off value 
could be derived from receiver operating characteristic curve (ROC) analysis. (Faye et al., 
2011). Furthermore, gains in test specificity may be achieved by including additional antigens 
or different antigen combinations or other test modifications. In addition, solutions such as the bovine TB Test  
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serial use of the SIT with IFN-γ should be explored as this may result in sensitivities not 
lower than those achieved with SICCT and specificities closer to 1.  
4.8.  Future perspectives 
The information provided by this opinion indicates that the sensitivity and specificity of a 
bovine TB test may vary considerably from one population to another, even if the same test 
protocols are used. A likely reason is that populations differ with respect to infection history 
resulting  in  a  different  distribution  of  the  various  stages  of  infection  and  a  different 
distribution of infections with other Mycobacteria. As a consequence, the probability that a 
test negative animal or herd is truly bovine TB free may vary from one population to another.  
This problem is not unique for bovine TB, but is general for demonstrating freedom from 
infection.  
In response to this problem, in recent years surveillance frameworks have been developed that 
define and prescribe the required confidence in the freedom of infection to be obtained by the 
testing system instead of providing a detailed overview of the testing scheme itself. In this 
way the heterogeneity in local risk factors can be taken into account and the risk manager can 
chose the testing scheme (test, sample size and sampling frame) to best obtain the required 
confidence of freedom (EFSA, 2008, More et al 2009). This approach to surveillance has the 
potential to provide higher confidence of freedom and is more cost effective than surveillance 
based on a prescribed testing scheme (Cameron, 2012). Nevertheless, the development of a 
surveillance program based on confidence of freedom for bovine TB in domestic ruminants 
still needs more work and, moreover, the practical implementation of such a program  is as 
yet not straightforward.   bovine TB Test  
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
TOR 1  To issue a scientific opinion on the suitability of the IFN-γ test for inclusion in the 
official tests for the purpose of granting and retaining official bovine TB-free herd status, as 
laid down in Annex A to Directive 64/432/EEC, and certification for intra-Union trade in 
bovine animals, as required in Article 6(2)(a) of that Directive 
In this assessment a test was considered suitable if it 1) has sensitivity equivalent or superior 
to the current standard tests used in the EU, 2) has specificity not lower than that of the 
current standard test with lowest specificity used in the EU and 3) is practical in its use. Under 
this definition of suitability, the majority of the data indicate that PPD-based IFN-γ could be 
included among the official tests. However, analysis of data obtained for this opinion suggest 
that in some populations the specificity may not be as high as the SIT the standard test with 
the lowest specificity currently used in the EU.  
There is insufficient evidence upon which to base a definitive conclusion about the suitability 
of IFN-γ tests using defined antigens, although available information on the  ESAT-6 and 
CFP-10 antigens of this test suggests that they have higher specificity than that of PPD based 
IFN-γ tests, without marked loss of sensitivity. This remains to be fully evaluated. 
ToR 2  To issue a scientific opinion on the suitability of other, possibly newer, tests, if any, for 
inclusion in the official tests for the purpose of granting and retaining official bovine TB-free 
herd status, as laid down in Annex A to Directive 64/432/EEC, and certification for intra-
Union trade in bovine animals, as required in Article 6(2)(a) of that Directive 
Other tests evaluated did not meet the suitability criteria applied in this assessment. 
ToR 3  In the event of a negative opinion to point (1), to advise the Commission on which 
further validation studies are necessary to evaluate the suitability of the IFN-γ test, or any 
other new test, for inclusion in the official tests for the purpose of granting and retaining 
official bovine TB-free herd status, as laid down in Annex A to Directive 64/432/EEC, and 
certification for intra-Union trade in bovine animals, as required in Article 6(2)(a) of that 
Directive 
The conclusion to ToR 1 was not negative. Nonetheless, there is still uncertainty regarding 
whether the specificity of the PPD-based IFN-g test is always as high as that of the current 
tuberculin skin test with lowest specificity. 
RECOMMENDATIONS 
ToR 1 
Should the PPD-based IFN-γ test be included in the official tests for the purpose of granting 
and retaining official bovine TB-free herd status, it is recommended that the protocols for its 
use for this purpose are harmonised in the EU. 
ToR 3 
Further  validation  of  the  IFN-γ  test  should  evaluate  the influence  of  factors, such as the 
presence of environmental mycobacteria, the prevalence of bovine TB in the herd, the age and 
bovine TB test history of the animals, and the type of production system, that may affect the 
test specificity and hence the suitability of the test for demonstrating freedom from bovine TB 
in different situations. bovine TB Test  
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Well  designed  studies  to  further  evaluate  the  diagnostic  performance  of  IFN-γ  test  using 
defined antigens (e.g. ESAT-6 and CFP10) should be conducted. These studies should be 
carried out in parallel with PPD based IFN-γ tests in a single assay, and conclusions reached 
on whether the combined use of different antigens can optimise and improve the overall 
performance of the IFN-γ test. 
The potential for the serial use of the IFN-γ test and the skin test (whereby positive test results 
are confirmed by a second test) to increase the specificity of the test protocol with limited loss 
of sensitivity should be assessed. bovine TB Test  
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APPENDICES 
A.  EXCLUDED TESTS AND REASONS FOR EXCLUSION 
Table 5:    Diagnostic tests excluded  from  the  evaluation (adapted from  Annex  1  of 
AHVLA systematic review (VLA, 2011) 
Test name  Long description  Large-
scale 
survey of 
live 
animals  
Sufficient 
evaluation 
Culture   Bacterial culture  NO  YES 
Glutaraldehyde  Glutaraldehyde test  YES  NO 
Microscopic 
examination 
Microscopic examination  NO  YES 
Post mortem (meat 
inspection) 
Meat inspection at the slaughterhouse  NO  YES 
Post  mortem 
(detail/laboratory) 
Post-mortem examination in a laboratory  NO  YES 
Bentonite 
flocculation test 
 
Bacillary extracts of attenuated M. bovis (BCG) are 
fractionated on diethylaminoethyl cellulose to yield 
a carbohydrate fraction which sensitises  bentonite 
to  react  with  serum  antibodies  to  M.  bovis.  The 
degree of flocculation (precipitation) is graded with 
higher flocculation indicating a positive response. 
Purified  BCG  carbohydrate  fraction  or  old 
tuberculin is used to cause sensitisation 
NO  NO 
Clinical signs  Ante-mortem diagnosis based upon symptoms such 
as the following:  
Body condition: thin, very thin, emaciated 
Respiratory  signs:  chronic  cough,  elicited  cough, 
respiratory distress, swollen mammary gland lymph 
nodes and superficial lymph nodes 
Externally  visible  lesions:  head  nodes,  neck 
(cervical)  nodes,  udder  tissue,  supramammary 
nodes, skin, prescapular nodes, other nodes 
NO  YES 
Complement 
fixation tests 
Immunological test that can be used to detect the 
presence  of  either  specific  antibody  or  specific 
antigen in serum  
YES  NO 
Diagnostic 
anatoxin 
Experimental variation of the intradermal skin test  NO  NO 
Dot-immunogold 
silver  staining 
(Dot-IGSS) 
The  procedure  is  based  on  a  two-step  incubation 
using  a  primary  antibody  and  a  gold-labelled 
secondary antibody conjugate 
YES  NO 
Double intradermal 
test  (see  also  the 
Stormont test) 
Official test in the UK until 1940. Two injections of 
mammalian  tuberculin  (one  48  hours  after  the 
other) and measurement of skin thickness 24 hours 
later 
YES  NO 
Expression  of 
IL2R, IL4, IL10 or 
TNF-α 
Expression  of  cytokines  in  blood  in  response  to 
infection.  PPD  antigens  are  presented  to 
lymphocytes and the production of cytokine from 
the  stimulated  T  cells  is  measured  in  an  ELISA 
format 
NO  NO 
Flocculation/ 
Meinicke 
flocculation 
reaction 
A  precipitin  test  characterised  by  a  flocculent 
precipitate of antigen and antibody 
NO  NO bovine TB Test  
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Fluorescence lamp  Smears from culture of M. bovis examined using a 
fluorescence lamp 
NO  NO 
Haemagglutination 
test/passive 
haemagglutination 
(PHA) 
test/Middlebrook/
Middlebrook–
Dubos 
Serological  test  based  on  the  agglutination  by 
tuberculous antiserum of sheep red cells sensitised 
with a carbohydrate extract of tubercle bacilli 
NO  NO 
Haemolytic/ 
haemolysis/ 
haemolysin test  
Modification of the haemagglutination test whereby 
complement  is  added  to  the  antigen  and  serum 
causing  haemolysis  rather  than  haemagglutination 
in the presence of serum containing antibodies to 
TB  
NO  NO 
Indirect fluorescent 
antibody (IFA) test 
Serological test to detect circulating antibodies to 
M. bovis using any antigens/conjugates including  
FITC-anti-bovine IgG and IgM conjugates 
YES  NO 
LCx  amplification 
assay 
Commercial  assay  using  ligase  chain  reaction  to 
amplify DNA targets in M. tuberculosis complex 
NO  NO 
Leucocyte 
formation 
Blood component count technique    NO 
Lymphocyte 
immunostimulation 
test  
Response  of  lymphocytes  in  blood  to  M.  bovis 
antigens compared to response in control samples 
YES  NO 
M.  tuberculosis 
(complex)  direct 
test 
Direct target-amplified nucleic acid probe test for 
the in vitro diagnostic detection of M. tuberculosis 
complex rRNA in acid-fast bacilli smear – positive 
and negative concentrated sediments from sputum, 
bronchial  specimens,  or  tracheal  aspirates.  The 
tuberculosis  complex  consists  of  M.  tuberculosis, 
M. bovis, M. bovis BCG, M. africanum, M. canetti 
and M. microti 
NO  NO 
Ophthalmic test  Tuberculin is administered into the eye. Congestion 
of  the  conjunctiva  with  a  serofibrinous  exudate 
after 6–16 hours is a positive result 
NO  NO 
Patch test  Ointment  containing  dead  bovine  tubercle  bacilli 
and bovine tuberculin are applied to a shaved and 
washed area on  the posterior aspect of the thigh, 
and covered with sticking plaster. A control area is 
covered  with  sticking  plaster  only.  Reactions 
compared at 48 hours 
NO  NO 
Radiometric 
detection 
Monitors  carbon  dioxide  released  from  a  broth 
medium containing radioactively labelled substrate 
NO  NO 
Stormont test  Variation of the double intradermal skin test. Two 
injections of tuberculin, the second 7 days after the 
first.  The  injection  site  is  measured  before 
reinjection and 24 hours later; an increase of 5 mm 
or more is considered a positive reaction 
YES  NO 
Thermal test  A  large  quantity  of  tuberculin  (e.g.,  Koch’s  old 
tuberculin) is injected into a cow’s veins and her 
temperature measured. If the cow develops a rise in 
body  temperature  of  at  least  1.5 ºF,  peaking  no 
lower  than  103.2 ºF,  the  cow  is  classified  as  a 
reactor 
NO  NO 
Tube gel 
precipitation 
technique/gel 
double diffusion 
test/precipitation 
Serological  test  demonstrating  localised 
precipitation  from  the  diffusion  of  antigen  to  its 
antibody in gel 
YES  NO bovine TB Test  
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test 
Vernes  test/Vernes 
flocculation test 
Serological  test:  Vernes-Bricq-Yvon  photometer 
used  to  measure  flocculation  occurring  over  a  4-
hour period in a mixture of serum and resourcinol 
NO  NO 
BCG, bacille Calmette-Guérin; FITC, fluorescein isothiocyanate; Ig, immunoglobulin; IL, interleukin; LCx, …; 
TNF, tumour necrosis factor. 
   bovine TB Test  
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B.  DIAGNOSTIC TESTS FOR BOVINE TB 
Skin test  
The  detection  of  early  infection  is  dependent  on  measuring  the  cell-mediated  immune 
responses that predominate in the early stages of the disease and which involve recruitment 
and activation of a variety of T cells to the site of infection (Pollock et al., 2005). These 
responses, however, can be measured peripherally, and this has been exploited through the 
development of several immunological diagnostic assays that have proven very effective in 
diagnosing TB both in cattle and in humans (de la Rua-Domenech et al., 2006).  
The most widely used field test for the diagnosis of TB in cattle is the tuberculin skin test, 
which measures the cell-mediated immune response to M. bovis infection (Monaghan et al., 
1994). The tuberculins currently in use in the EU contain a crude mixture of predominantly 
secreted mycobacterial proteins derived from specified strains of M. bovis (Andersen et al., 
1994;  Inwald  et  al.,  2003).  Many  of  these  antigens  are  also  found  in  non-pathogenic 
environmental mycobacterial species and this cross-reactivity to common antigens can result 
in reduced specificity of the test (Francis et al., 1978; Monaghan et al., 1997). For this reason, 
an M. avium-derived tuberculin is included in the comparative tuberculin test.  
Interpretation  of  the  SIT  is  based  on  observing,  measuring  and  recording  72  hours  after 
intradermal  inoculation  of  bovine  tuberculin  (bovine  PPD)  the  nature  and  extent  of  any 
increase in skin thickness at the site of inoculation. In the comparative test (SICCT) this 
response is also compared with that observed 72 hours after inoculation of avian tuberculin 
(avian PPD) at an adjacent site on the neck of the animal. The single test takes only the 
bovine PPD site into account and, consequently, this test is more sensitive but less specific 
than the comparative test (Karolemeas at al., 2012). When the standard interpretation of the 
tests is applied, inconclusive reactors must be subjected to an additional skin test at least 42 
days after the previous one; if they are not negative in the second test, they are deemed 
positive. However, to maximise sensitivity of the test a severe interpretation may be applied 
(particularly in areas of high prevalence), in which all inconclusive reactors in the first skin 
test are considered as positive and removed for slaughter (Anonymous, 2006).Variations in 
the types of tuberculin used and the strictness of the interpretation of the test results, which 
both modulate sensitivity and specificity, can all directly affect sensitivity and specificity.  
Post-mortem and bacteriological examination 
Post-mortem examination of cattle, and bacteriological examination of appropriate tissues 
including lymphatic nodes, are critical steps in the confirmation of the diagnosis of TB in 
cattle  (Costello  et  al.,  1998).  In  meat  plants,  the  detection  of  gross  lesions  of  TB  on  a 
presumptive  basis  at  routine  meat  inspection  of  carcasses  is  often  routinely  employed  to 
screen for infected animals. A tentative diagnosis of bovine TB can be made following the 
finding of typical tuberculous lesions during necropsy. Culturing is rarely required when the 
disease frequency is high and the cost of misdiagnosis, in terms of the cost of consequential 
action, is negligible. Conversely, in a disease-free area or  one with very low prevalence, 
culturing is usually needed to ascertain M. bovis infection.  
The inspection procedure employed to examine cattle that are slaughtered as reactors to a 
tuberculin test can take one or three forms, namely: 
(1) An examination of tissues and organs for macroscopic lesions, conducted either in situ at 
the meat plant at the time of the post-mortem carcass inspection. This is considered adequate 
and sufficient when bovine TB is endemic and the prevalence of disease is high. bovine TB Test  
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(2) The aseptic collection of tissues displaying lesions for histopathological examination in a 
laboratory, possibly associated with PCR and/or bacterial culture, especially if microscopic 
lesions suggestive of TB are observed.  
(3) If no macroscopic lesions are observed (no visible lesions), lymph nodes may nevertheless 
may be sampled in order to carry out PCR and/or bacterial culture.  
To determine the true infection status and true TB status of cattle that give a positive reaction 
in diagnostic tests but have no visible lesions (NVL) reported following routine post-mortem 
inspection in the meat plant, a laboratory-based bacteriological examination is often necessary 
(Costello et al., 1998). The classification of M. bovis-infected animals with NVLs disclosed at 
slaughter may arise as a result of recent infection, poor post-mortem inspection technique or 
infection  with  mycobacteria  other  than  M.  bovis.  When  successful,  and  where  cross-
contamination of the sample during collection at the point of initial inspection can be ruled 
out,  a  positive  culture  for  M.  bovis  is  considered  as  the  definitive  gold  standard  for  the 
diagnosis  of  TB  in  cattle.  The  degree  of  sensitivity  of  the  inspection  procedure  for  the 
detection of lesions at slaughter in meat plants is influenced, inter alia, by the time devoted to 
the inspection and the diligence of the inspectors conducting the inspection.  
IFN-γ assay  
Arising from the need to increase the detection rate of M. bovis-infected animals in exposed 
herds,  the  IFN-γ  assay  was  developed  in  Australia  as  an  ancillary  test  to  improve  the 
sensitivity of testing of cattle when used in parallel with the tuberculin test. The principle of 
the assay is to use ELISA technology to detect and quantify release of the IFN-γ cytokine 
when heparinised whole blood is incubated with bovine and avian (PPD) tuberculin within the 
first 8–24 hours post collection (Rothel et al., 1990). During the first stage of the test blood 
samples collected from cattle are transported to the laboratory and stimulated overnight with 
tuberculin. In the second stage of the test, the plasma is harvested from the stimulated blood 
and is assayed for the presence of IFN-γ. The different optical density (OD) readings obtained 
after stimulation with each antigen (bovine PPD/avian PPD/PBS, used as a blank) are then 
used to yield a quantitative result: OD obtained after stimulation with PBS (NILOD) is often 
subtracted from the OD observed after stimulation with bovine PPD (PPDbOD) and avian PPD 
(PPDaOD); these two figures (PPDbOD – NILOD and PPDaOD – NILOD) are then compared and, 
depending on the cut-off in place, an animal is considered a reactor or not. The potential of 
other more specific antigens (mainly ESAT6/CFP10) for induction of specific release of IFN-
γ is also currently under evaluation. Results from experimental and natural infections of cattle 
indicate that the assay can detect a cell-mediated immune response to infection as early as 14 
days post infection, and earlier than the tuberculin test (Buddle et al., 1995). 
According to the EU legislation, Member States may authorise the ancillary use of the IFN 
assay to “enable detection of the maximum number of infected animals in a herd or in a 
region in addition to the tuberculin test” (Directive 64/432/EEC). Its parallel implementation 
increases the sensitivity of the diagnostic regime, although it can also cause a decrease in 
diagnostic specificity. Therefore, its use is not recommended on a routine basis in areas or 
regions  where  the  herd  prevalence  is  low  (Anonymous,  2006).  In  certain  countries/areas 
(usually free of disease) the IFN assay is used in surveillance programmes following non-
negative results to skin tests (serial use of the tests), in order to increase the specificity of the 
overall diagnostic procedure (Table 6). The EU regulation, however, does not include this 
serial use of the IFN-γ test.    bovine TB Test  
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Antibody detection tests  
In countries with managed surveillance systems, the majority of infected animals disclosed by 
the tuberculin test and, in particular, IFN-γ tend to be in the early stages of the disease and 
display  few, if any,  visible  lesions  upon  post-mortem  examination  (Pollock  et  al.,  2005). 
However, there is a category of M. bovis-infected animals that is consistently missed by the 
tests targeting the cell-mediated immune response (Lepper et al., 1977; Yearsley et al., 1998). 
Sometimes described as “anergic”, these animals may in time develop generalised disease 
with extensive lung lesions and, as such, pose a serious threat to the health of herd owners and 
those with whom they come in contact, as well as to the health of other cattle. The reasons for 
anergy are unclear, although it can be attributed to a number of causes, e.g., the animal may 
be  unable  to  mount  a  detectable  cellular  immune  response  to  infection  or  the  immune 
response is impaired  – possibly owing to intercurrent pathogens with immunosuppressive 
effect (Claridge et al., 2012), or in some cases rapid progression of the disease may result in 
suppression of responses (Managhan et al., 1994).  
As the disease progresses there is a shift in the balance of the immune response away from the 
predominant cell-mediated immune response and towards an antibody response (Ritacco et 
al., 1991; Pollock & Neill, 2002). These antibodies are generally targeted at immunodominant 
antigens  that  elicit  a  humoral  response,  notably  MPB70  and  MPB83    released  in  large 
amounts by M. bovis in the later stages of the disease. A variety of ELISA tests have been 
developed  that  depend  on  the  detection  of  high  levels  of  circulating  antibodies  to  the 
immunodominant antigens of M. bovis (Whelan et al., 2008; Green et al., 2009; Waters et al., 
2011).  It  has  been  reported,  however,  that  the  antibody  response  can  be  boosted  (the 
anamnestic  response)  by  a  prior  tuberculin  test  (Thom  et  al.,  2004).  Much  of  the  recent 
technological effort has focused on developing in vitro field tests that can rapidly provide a 
reliable test result. Recent studies using lateral flow chromatography technology incorporated 
into a rapid serological test format have shown that the sensitivity of the tests in question, 
when used in cattle, increases as the disease progresses post infection (Waters et al., 2006). bovine TB Test  
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Table 6:   Current use of IFN-γ in the European Union
(a) 
Country  Official 
status 
Antigen 
(manufacturer) 
Tested population  Combined use 
with the skin 
test 
(parallel/serial) 
Time between collection of 
samples and processing in the 
laboratory 
Cut-off point 
Austria  OTFC  PPDs (Prionics)   N.A.  N.A.   Processing  within  the  first  24 
hours after blood collection 
PPDbOD – NILOD > 0.1; 
PPDbOD-PPDa > 0.1 
Belgium  OTFC  PPDs  (Synbiotics), 
CFP-10/ESAT-6 
N.A.  N.A.  Processing  within  the  first  8 
hours post collection 
PPDbOD/NILOD > 2.0  and 
NILOD < 0.15  (Invitrogen 
kit) 
France  OTFC  PPDs (Prionics), CFP-
10/ESAT-6 
(1)  Cattle  in  infected 
herds  (selective 
culling) 
(2)  Reinforced 
surveillance  in  high-
risk areas 
Parallel  Processing  within  the  first  8 
hours post collection 
(PPDb – PPDa)/(PC –
 NC) ≥ 0.05 
(E/C – PBS)/(PC –
 NC) ≥ 0.015 
PPDs (Prionics), CFP-
10/ESAT-6 
Surveillance  in  some 
areas  with  low 
prevalence  (nine 
districts)  
Serial  (reactors 
to ST) 
(blood sampling 
for  IFN  72 
hours after ST) 
Processing  within  the  first  8 
hours post collection 
(PPDb – PPDa)/(PC –
 NC) ≥ 0.05  
(E/C-  PBS)/(PC-
NC) ≥ 0.015 
    PPDs (Prionics)  Bullfighting  herds  in 
Camargue  
In  parallel  with 
ST or as stand-
alone test 
Processing  within  the  first  8 
hours post collection 
PPDb – PPDa)/(PC –
 NC) ≥ 0.04 
Germany  OTFC  PPDs (Prionics)  Cattle in infected herds  Parallel  Processing  within  the  first  30 
hours post collection 
PPDbOD – NILOD ≥ 0.1; 
PPDbOD > PPDaOD 
Netherlands  OTFC  PPDs  (Prionics), 
Peptide  cocktail 
(VLA) 
Cattle in positive herds  Serial  Processing within the first 8/24 
hours post collection 
PPDbOD – NILOD ≥ 0.05 
(eradication);  
PPDbOD – NILOD ≥ 0.1 
(screening);  
PPDbOD – PPDaOD > 0.1 
Poland  OTFC  PPDs  (Australian 
Prionics) 
Cattle with positive or 
inconclusive  reactions 
Serial  Processing 24 hours after blood 
collection 
PPDbOD – NILOD ≥ 0.05; 
PPDbOD > PPDaOD bovine TB Test  
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to skin test 
Greece  Non-OTFC  PPDs (CZ Veterinaria)  Cattle with positive or 
inconclusive  reactions 
to skin test 
Serial  Processing  within  the  first  24 
hours post collection 
PPDbOD – NILOD ≥ + 0.1; 
PPDbOD – PPDaOD ≥ 0.1 
Hungary  Non-OTFC  N.A.  N.A.  N.A.  Processing  within  the  first  8 
hours post collection 
PPDbOD ≥ PBSNILOD + 0.1; 
PPDbOD > PPDaOD + 0.1 
Ireland  Non-OTFC  PPDs (Prionics)  High  risk  cohorts  in 
infected herds 
Parallel  Processing  within  the  first  8 
hours post collection 
PPDbOD – NILOD ≥ 0.05; 
PPDbOD ≥ PPDaOD;  
PPDbOD > 0.1 
Italy  Non-
OTFC/OTFR 
PPDs (Prionics)  Cattle in infected herds  Parallel  Processing  within  the  first  8 
hours post collection 
PPDbOD/NILOD ≥ 2;  
PPDbOD – PPDaOD ≥ 0.05 
Portugal  Non-OTFC  PPDs (CZ Veterinaria)  Cattle in infected herds  Parallel  Processing  within  the  first  8 
hours post-collection 
PPDbOD – NILOD ≥ 0.05; 
PPDbOD > PPDaOD 
Romania  Non-OTFC  PPDs  (SN  Inst. 
Pasteur SA- Romania) 
PPDs  (Lelystad 
Biologicals  BV -
Nederlands) 
At  the  Romanian 
National  Authority’s 
request  for  expertise, 
or  at  the  owner’s 
request (with payment) 
N.A.  Processing  within  the  first  30 
hours post collection 
PPDbOD – NILOD ≥ 0.1; 
PPDbOD > PPDaOD + 0.1 
Spain  Non-OTFC  PPDs (CZ Veterinaria)  Cattle in infected herds  Parallel  Processing  within  the  first  8 
hours post collection 
PPDbOD – NILOD ≥ 0.05; 
PPDbOD > PPDaOD 
United Kingdom 
(England  and 
Wales) 
Non-OTFC  PPDs  ( Prionics) 
(99.25 %) 
Cattle in infected herds  Parallel  Processing 24 hours after blood 
collection 
PPDbOD – PPDaOD > 0.1 
ESAT-6/CFP-10 
(0.75 %) 
Herds  with  non -
specific 
reactors/suspicions  of 
fraud 
Serial  Processing 24 hours after blood 
collection 
ESAT6/CFP10OD–NILOD 
> 0.1 
(a)  Source: First technical meeting of the EFSA Scientific Network on Tuberculosis Testing, National Reference Laboratories of the Member States, EU Reference Laboratory for Bovine 
Tuberculosis. 
N.A., information not available; NC, negative control; PC, positive control.  bovine TB Test  
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C.  SYSTEMATIC LITERATURE REVIEW 
In 2008, with funding from Defra,
7 the AHVLA
1 set up a working group (WG) to conduct a systematic 
review and meta-analysis of the performance of diagnostic tests for bovine  TB in cattle. The WG 
included 18 reviewers, from within the AHVLA and from outside organisations, with a scientific 
expertise ranging from TB immunology to pathology and laboratory culture of M. bovis to veterinary 
epidemiology and implementation of TB control programmes (Downs et al., 2011, VLA, 2011).  
The process of the review was discussed and agreed by the WG. The methodology was adapted from 
an approach taken previously while reviewing the performance diagnostic tests for TB in deer (EFSA, 
2008). Comprehensive search criteria were developed and the process of  the review standardised. 
Sources of references included:  
1.  Electronic databases including: 
  Web of Knowledge (includes Web of Science 1995–, Current Contents 1998–, CAB Abstracts 
1910–, Medline 1950–) 
  Dialog (includes Embase 1974–, Agricola 1970–, Agris 1975–) 
2.  Unpublished  data  and  reports  identified  through  contacting  research  institutions  and 
laboratories (grey literature) 
3.  References known to members of the WG  
4.  Review of bibliographies of reports and papers  
The final search of electronic databases was carried out on 1 December 2008, with no limits applied 
by year, language, region or type of diagnostic test, using the following search string: 
 (bovine tuberc* or mycobacterium bovis*) or ((mycobact* not (paratub* or johne*)) 
AND 
(bovin* or cattle or cow or cows or calf or calves or buffa)  
AND 
(test* or screen* or diagn* or eia or elisa or pcr or polym* chain react* or lympho* or interferon or 
skin  or  rapid  or  detect*  or  peptid*  or  cervical  or  caudal  or  sicct  or  antibody*  or  necroscopy  or 
necropsy  or  survei*  or  sensitivi*  or  specifici*  or  perform*  or  eval*  or  valid*  or  accura*  or 
confirmatory) 
9 782  potentially  eligible  references  were  identified  initially  by  the  electronic  search  and  other 
sources. In order to be included in the final review and meta-analysis, the references identified as 
potentially eligible had to pass through two stages of review.  
The stage 1 review of abstracts, where available, and titles was conducted by two reviewers. The 
inclusion and exclusion criteria were as follows: 
Inclusion criteria:  
  the reference related to primary research;  
                                                       
7  The UK Government Department for Environment, Food and Rural Affairs.  bovine TB Test  
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  the reference included either report(s) of sensitivity and/or specificity of a diagnostic test for 
TB, or provided data enabling the statistics to be calculated; 
  the diagnostic test performance was measured on cattle. 
Exclusion criteria: 
  the sensitivity estimates were from studies in which cattle had been experimentally infected 
with M. bovis . 
Entire  references  of  those  that  passed  through  the  stage  1  review  were  obtained  and  randomly 
allocated to two reviewers
8 for detailed review at stage 2.  
Inclusion and exclusion criteria at stage 2: 
Inclusion criteria for sensitivity estimates: 
  sensitivity could be calculated; 
  the bovine population had been naturally exposed to TB;  
  each study animal had been individually examined using one of the following reference tests: 
post-mortem  examination  (meat  inspection  or  detailed  laboratory  inspection),  culture, 
microscopic inspection (histology or histopathology), SICCT test. 
Exclusion criteria:  
  the study population had been experimentally infected with M. bovis; 
  The definition of “infected” was based on a “group” level inference (such as a sample of 
animals in the study population being positive for culture of M. bovis).  
Inclusion criteria for specificity estimates: 
  specificity could be calculated; 
  there is good evidence that the bovine population was free from infection with, and exposure 
to, M. bovis, including herds with officially TB free (OTF) status, herds from an OTF area or 
OTF country, herds from a non-endemic TB area where the authors stated that the area has 
been free of TB for several years, or herds that in the authors’ opinion was TB free and had 
been free of TB for several years. 
Exclusion criteria: 
  any other evidence of lack of exposure to TB. 
Reference papers that appeared to have eligible data were also reviewed by the reviewers using the 
QUADAS (Quality Assessment of Diagnostic Accuracy Studies) instrument developed by Whiting et 
al. (2006), adapted for the veterinary use. Each reviewer extracted the agreed range of data from the 
references they considered met the eligibility criteria and entered the data on to individual copies of 
the bespoke database. Data entered into the stage 2 databases by the two reviewers were compared 
using a query system and a hierarchical process was followed to resolve inconsistencies.  
                                                       
8  Reference papers and reports written in English and Spanish were reviewed by two reviewers. References written in other 
languages were reviewed by one reviewer. bovine TB Test  
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There  were  119  references  (published  1934–2009)  with  eligible  estimates  of  diagnostic  test 
performance for 14 different diagnostic tests.  
Pooled unadjusted estimates of performances for the different diagnostic tests and modifications of the 
tests were calculated. This was followed by modelling to control for confounding factors and the 
structure of the data, which comprised varying numbers of records per reference, population and test 
type. The estimation of sensitivity and specificity was carried out separately for each test type because 
performance estimates were derived from different study populations. Stepwise logistic regression was 
conducted to identify confounding factors such as country of study, year of study, sampling strategy, 
evidence  of  cross-reactivity  with  environmental  mycobacteria,  animal  production  type,  type  of 
reference  standard,  interpretation  of  tuberculin  response  (skin  test),  tuberculin  used  in  skin  test, 
diagnostic antigen (in blood tests), whether the blood test was performed before or after the skin test 
and others. Relative differences in performance due to cut-off used to define a positive response in the 
IFN-γ and ELISA blood tests were adjusted for by including a “counter parameter” in the model. The 
counter parameter was the corresponding estimate of specificity (reported in the reference) where 
sensitivity was being estimated and the corresponding estimate of sensitivity where specificity was 
being estimated. Where the corresponding estimate of test performance was not reported within the 
reference, the median sensitivity or specificity from the range of values estimated for the test was 
imputed. Covariates remaining in the models after the stepwise procedure were then used in logistic 
regression modelling with a random effect term to account for reference run in a Bayesian framework 
implementing the Monte Carlo Markov Chain technique. Final estimates were reported with categories 
best representing test conditions in GB and in Ireland as baseline. Performance estimates for tests 
considered for the EFSA mandate are reported in Table 3. Further results and estimates for other tests 
and details of the AHVLA systematic review and meta-analysis procedure can be found in the final 
report on the study and its accompanying annexes and appendices (VLA, 2011). 
   bovine TB Test  
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D.  UPDATE OF THE LITERATURE REVIEW 
Searches were conducted to identify any new data on diagnostic test performance that had become 
available since the original searches for the AHVLA review (VLA, 2011). The search of electronic 
databases for the AHVLA systematic review was last performed on 1 December 2008. The update was 
done by EFSA on 13 March 2012 using the same search string without language restrictions on Web 
of Knowledge (which simultaneously searches Web of Science 1995 , Current contents 1998–, CAB 
abstracts 1910–, Medline 1950–). 
(bovine tuberc* or mycobacterium bovis*) or ((mycobact* not (paratub* or johne*)) 
AND 
(bovin* or cattle or cow or cows or calf or calves or buffa)  
AND 
(test* or screen* or diagn* or eia or elisa or pcr or polym* chain react* or lympho* or interferon or 
skin  or  rapid  or  detect*  or  peptid*  or  cervical  or  caudal  or  sicct  or  antibody*  or  necroscopy  or 
necropsy  or  survei*  or  sensitivi*  or  specifici*  or  perform*  or  eval*  or  valid*  or  accura*  or 
confirmatory) 
The search retrieved 946 results for review. 
The inclusion criteria considered for stage 1 of the review (relevance screening based on title and 
abstract) were: 
  the reference is related to primary research; 
  the reference included either report(s) of sensitivity and/or specificity of a diagnostic test for 
TB or provides data enabling these statistics to be calculated; 
  the diagnostic test performance was measured on cattle; 
  the reference includes reports on the performance of any of the following tests: IFN- , ELISA, 
LBBA, multiplex and/or rapid. 
  the specificity estimates were from bovine tuberculosis free cattle population unless latent 
class analysis was used. 
The exclusion criteria used was: 
  the sensitivity estimates were from studies in which cattle had been experimentally infected. 
Each record was reviewed by two reviewers; if either of the reviewers considered the reference was 
relevant, it was included for stage 2 screening. Where there was insufficient information to determine 
whether stage 1 criteria were met, the reference automatically passed to stage 2. 
The stage 1 review yielded 124 records.  
The stage 2 review consisted of a review of titles and abstracts by two reviewers, and all conflicts 
(non-agreement  between  reviewers)  were  discussed  and  screening  of  the  full  text  made  when 
necessary to reach agreement. The criteria were the same as in stage 1. The stage 2 review yielded 15 
records. Data extracted from these studies are summarised in Table 7. bovine TB Test  
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Table 7:    Estimates of sensitivity and specificity and 95% confidence intervals (CI, calculated when possible) from included studies in the updated 
literature review.  
Reference  Test 
name 
Criteria 
(a) 
Population 
(b) 
N  Approach 
(c) 
Test used as 
comparator or 
reference 
Sensitivity  Lower 
95% 
CI 
Upper 
95% 
CI 
Specificity  Lower 
95% 
CI 
Upper 
95% 
CI 
Comments 
Marassi  et  al., 
2010 
ELISA-
MPB  
12  Other   32  GS  Culture positive or 
PCR + SICCT 
0.344      0.750      Cut-off  points  based 
on OD readings were 
calculated using ROC 
curves 
Waters  et  al., 
2011 
ELISA-
MPB 
12  OTFH  1473  GS  SICCT/Culture        0.98      No  measures  of 
spread  reported, 
herds  sourced  from 
four  different 
countries 
Waters  et  al., 
2011 
ELISA-
MPB 
12  OUT  478  GS  SICCT  Standard/ 
culture 
0.630            No  measures  of 
spread  reported  
herds  sourced  from 
four  different 
countries 
Jeon  et  al., 
2010 
ELISA-
MPB 
12  Other  109  GS  Caudal fold  0.818  0.645  0.930        Measured in sera 
Mean + 3SD  of  OD 
in negative controls 
Jeon  et  al., 
2010 
ELISA-
MPB 
12  Other  109  GS  Caudal fold  0.879  0.718  0.966        Measured in milk 
Mean+3SD of OD in 
negative controls 
da  Silva  et  al., 
2011 
ELISA-
MPT-51 
12  OUT  262  GS  SICCT test  0.548  0.478  0.617        OD   1.301 
Du et al., 2011  ELISA-
rMPB70-
83-E6 
  OUT  111  GS  SIT 
cervical + culture 
positive 
0.378  0.288  0.475        Positive 
culture = strains  of 
Mycobacterium 
complex  isolated 
from  throat  swabs 
from  SIT-positive 
cattle 
S/P  0.5 
S/P = ((OD  of 
samples – OD  of 
negative 
controls)/(OD 
positive  controls –
 OD  negative 
controls)) bovine TB Test  
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da  Silva  et  al., 
2011 
ELISA-
Ag85 
12  OUT  262  GS  SICCT test  0.480  0.411  0.551        OD   0.898 
Silva  et  al., 
2011 
ELISA-
BCG 
12  OUT  262  GS  SICCT test  82.2  76.3  87.1        OD   1.287 
Alvarez  et  al., 
2012 
IFN-γ-
BA 
1  OUT  6202  LCA  SIT cervical  0.897  0.775  0.972  0.857  0.843  0.88   
Alvarez  et  al., 
2012 
IFN-γ-
BA 
2  OUT  6202  LCA  SIT cervical  0.833  0.719  0.916  0.904  0.891  0.927   
Antognoli et al., 
2011 
IFN-γ-
BA 
12  OTFH  4123  GS          0.97  0.965  0.975  Cut-off value   0.3 
Antognoli et al., 
2011 
IFN-γ-
BA 
12  OTFH  4123  GS          0.986  0.982  0.989  Cut-off value   0.5 
Antognoli et al., 
2011 
IFN-γ-
BA 
6  OTFH  4123  GS          0.907  0.898  0.916  Cut-off value   0.1 
Antognoli et al., 
2011 
IFN-γ-
BA 
12  OUT  87  GS  Culture  0.839  0.761  0.916         
Clegg  et  al., 
2011 
IFN-γ-
BA 
1    4937  LCA  Multiplex  (cut  off 
1)  and  SICCT 
standard 
0.666  0.631  0.701  0.881  0.868  0.894   
Clegg  et  al 
2011 
IFN-γ-
BA 
1    4937  LCA  Multiplex  (cut-off 
3)  and  SICCT 
standard 
0.716  0.678  0.742  0.877  0.863  0.89   
Clegg  et  al., 
2011 
IFN-γ-
BA 
1    4937  LCA  Multiplex  (cut-off 
5)  and  SICCT 
standard 
0.762  0.728  0.793  0.879  0.864  0.893   
Clegg  et  al., 
2011 
IFN-γ-
BA 
1    4937  LCA  Multiplex  (cut-off 
1)  and  SICCT 
severe 
0.641  0.608  0.675  0.887  0.874  0.9   
Clegg  et  al., 
2011 
IFN-γ-
BA 
1    4937  LCA  Multiplex  (cut-off 
5)  and  SICCT 
severe 
0.723  0.691  0.754  0.883  0.869  0.897   
Alvarez  et  al., 
2009 
IFN-γ-
BA 
1  OUT  46  GS  Culture  0.783  0.636  0.890         
Marassi  et  al., 
2010 
IFN-γ-
BA 
6  OUT  35  GS  SICCT/culture  or 
macroscopic 
lesions 
0.914  0.776  0.970         
Faye  et  al., 
2011 
IFN-γ-
BA 
12  OUT  60  GS  Culture  or 
macroscopic 
lesions 
0.83  0.72  0.92        Cut-off  including 
ODs  from  positive 
controls  of  the  plate. 
Used 3–10 after skin 
test bovine TB Test  
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Faye  et  al., 
2011 
IFN-γ-
BA 
12  OTFH  492  GS          0.994  0.982  0.999  Cut-off  including 
ODs  from  positive 
controls  of  the  plate. 
Used 3–10 after skin 
test 
Schiller  et  al., 
2009 
IFN-γ-
BA 
3  OUT  431  GS  Culture  and/or 
lesions 
90.9  0.878  0.935         
Schiller  et  al., 
2009 
IFN-γ-
BA 
3  OTFH  874  GS          0.965  0.950  0.976   
Clegg  et  al., 
2011 
IIFN-γ-
BA 
1    4937  LCA  Multiplex  (cut  off 
3)  and  SICCT 
severe 
0.682  0.651  0.713  0.881  0.867  0.894   
Faye  et  al., 
2011 
IFN-γ-
CE 
12  OUT  60  GS  Culture  or 
macroscopic 
lesions 
0.87  0.75  0.94        Cut-off  including 
ODs  from  positive 
controls  of  the  plate. 
Used 3–10 after skin 
test 
Faye  et  al., 
2011 
IFN-γ-
CE 
12  OTFH  492  GS          0.907  0.879  0.930  Cut-off  including 
ODs  from  positive 
controls  of  the  plate. 
Used 3–10 after skin 
test 
Whelan  et  al., 
2011 
Multiplex  12  OUT  60  GS  Culture  or 
macroscopic 
lesions 
0.883  0.774  0.952        Animals  negative  or 
inconclusive  in 
SICCT test 
Whelan  et  al., 
2010 
Multiplex    OUT  96  GS  Culture  and 
macroscopic 
lesions 
0.865  0.780  0.926        Cut-off Enfer 1 
Whelan  et  al., 
2010 
Multiplex    OUT  96  GS  Culture  and 
macroscopic 
lesions 
0.813  0.720  0.885        Cut-off Enfer 3 
Whelan  et  al., 
2010 
Multiplex    OUT  96  GS  Culture  and 
macroscopic 
lesions 
0.771  0.671  0.850        Cut-off Enfer5 
Whelan  et  al., 
2010 
Multiplex    OTFR  93  GS          0.796  0.7  0.8723  Cut-off Enfer 1 
Whelan  et  al., 
2010 
Multiplex    OTFR  93  GS          0.946  0.879  0.982  Cut off Enfer 3 
Whelan  et  al., 
2010 
Multiplex    OTFR  93  GS          1.000  0.950  1  Cut-off Enfer5 
Clegg  et  al., 
2011 
Multiplex      4937  LCA  SICCT severe and 
IFN 
0.642  0.610  0.674  0.922  0.910  0.933  Cut-off Enfer 1 bovine TB Test  
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Clegg  et  al 
2011 
Multiplex      4937  LCA  SICCT severe and 
IFN 
0.488  0.455  0.522  0.992  0.988  0.995  Cut-off Enfer 3 
Clegg  et  al., 
2011 
Multiplex      4937  LCA  SICCT Severe and 
IFN 
0.341  0.311  0.372  0.998  0.996  1.00  Cut-off Enfer 5 
Clegg  et  al., 
2011 
Multiplex      4937  LCA  SICCT  standard 
and IFN 
0.684  0.648  0.719  0.921  0.910  0.932  Cut-off Enfer 1 
Clegg  et  al., 
2011 
Multiplex      4937  LCA  SICCT  standard 
and IFN 
0.522  0.485  0.559  0.992  0.988  0.995  Cut-off Enfer 3 
Clegg  et  al., 
2011 
Multiplex      4937  LCA  SICCT  standard 
and IFN 
0.371  0.337  0.406  0.998  0.996  1.00  Cut-off Enfer 5 
Bermudez  et 
al., 2011 
Rapid    OUT  268    Culture  0.458  0.361  0.557         
Bermudez  et 
al., 2011 
Rapid    OUT  268    Direct PCR  0.488  0.403  0.578         
(a)  Positive if: value obtained in the blood sample stimulated with PBS, bovine PPD, avian PPD and specific antigens respectively 1-PPDbOD – NILOD > 0.05 and PPDbOD > PPDaOD;, 2-
PPDbOD – NILOD > 0.1  and  PPDbOD > PPDaOD;  3-PPDbOD – NILOD > 0.1  and  PPDbOD – PPDaOD > 0.1;  4-PPDbOD – PPDaOD > 0.04;  5-PPDbOD – PPDaOD > 0.05;  6-PPDbOD –
 PPDaOD > 0.1; 7-PPDbOD/NILOD > 2 and NILOD < 0.15, 8-Others PPD (please specify); 9-ANTIGOD – NILOD > 0.040; 10-ANTIGOD – NILOD > 0.050; 11-ANTIGOD – NILOD > 0.1; 12-
Others ANTIG. 
(b)  Source population status regarding bovine TB infection: OTFC, officially TB-free country; OTFR, officially TB-free region or province; OTFH, officially TB-free herd; OUT, outbreaks or 
reactors in the past 2 years in the same herds; NOOUT, not officially free but no outbreaks; OTHER, other. 
(c)  Methodology used to estimate sensitivity and specificity: LCA, latent class analysis; GS, gold standard. bovine TB Test  
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E.  PUBLIC DATA CALL 
EUROPEAN FOOD SAFETY AUTHORITY 
Call for data on Bovine Tuberculosis testing  
Published:  26 March 2012  
Deadline:  26 April 2012 
Background  
The Commission requested the European Food Safety Authority (EFSA) to issue a scientific opinion 
on the suitability of the IFN-γ test or other, possibly newer, tests for inclusion amongst the official 
tests for the purpose of granting and retaining an officially tuberculosis free herd status as laid down in 
Annex A to Directive 64/432/EEC and certification for intra Union trade in bovine animals as required 
in Article 6(2)(a) of that Directive furthermore.  
http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2011-01254  
Objective 
To address this question it must be assessed if the performance of the alternative tests, are equivalent 
or better when compared to the current standard test used in the European Union (EU).  
Characteristics of diagnostic accuracy will be considered. Diagnostic sensitivity (DSe) is defined as 
the probability of a positive test result in an infected animal, and diagnostic specificity (DSp) as the 
probability of a negative test result in an animal that is not infected.  
Call for data 
EFSA kindly asks governments, companies, universities, research institutions, other stakeholders and 
any  individuals  to  submit  any  available  data  concerning  diagnostic  test  accuracy  (sensitivity  and 
specificity). EFSA will evaluate the received data if data is in compliance with the following inclusion 
and exclusion criteria: 
Inclusion criteria:  
  The diagnostic test under evaluation (TUE) is one of the tests included in the Table 1. 
  The diagnostic test performance (diagnostic sensitivity and/or Sp) was measured on bovines 
  Each study animal had been individually examined using a official intradermal tuberculin test, 
either Single intradermal test (SIT) or Single intradermal comparative cervical test (SICCT) as 
the comparator test (CT) or with a reference standard (RT) for confirmation of infection by 
culture, microscopic examination or identification of macroscopic lesions. 
For a study to be included animals must have been tested by at least 2 of the tests considered  
Test under evaluation  Comparator test  Reference standard 
X  X   
  X  X 
X  X  X 
X    X 
 
1.  Additional data concerning testing of the same animals with other tests for confirmation of 
infection although valuable, is not essential. bovine TB Test  
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Exclusion criteria:  
  Any study where animals are experimentally infected with TB. 
Table 1 :Diagnostic tests to be evaluated (TEU) 
Test name  Abbreviation  Long description 
IFN-γ Bovine-Avian  IFN-γ-BA  Gamma - interferon test with bovine PPD and avian PPD diagnostic 
antigens 
IFN-γ Bovine  IFN-γ –B  Gamma - interferon test with bovine diagnostic antigen 
IFN-γ CFP10 ESAT6  IFN-γ –CE  Gamma  -  interferon  test  with  CFP10  and  ESAT6  diagnostic 
antigens 
IFN-γ MPB70  IFN-γ –MPB  Gamma - interferon test with MPB70 diagnostic antigen 
IFN-γ BACE  IFN-γ –BACE  Gamma - interferon test with bovine PPD and avian PPD diagnostic 
antigens and CFP10 and ESAT6 diagnostic antigens 
IFN-γ OTHER  IFN-γ -OTHER  Gamma  -  interferon  test  with  OTHER  diagnostic  antigens  – 
PLEASE SPECIFY 
ELISA  Bovine-
Avian 
Elisa-BA  Enzyme-linked immunosorbant assay  with bovine PPD and avian 
PPD diagnostic antigens 
ELISA Bovine  Elisa-B  Enzyme-linked  immunosorbant  assay  with  bovine  diagnostic 
antigen 
ELISA MPB70  Elisa-MPB  Enzyme-linked  immunosorbant  assay  with  MPB70  diagnostic 
antigen 
Latex  Bead 
Agglutination assay 
Latex  Latex bead agglutination assay (LBAA) 
Multiplex 
immunoassay 
Multiplex  Multiplex  chemiluminescent  immunoassay  developed  by  Enfer 
Scientific 
Serological Rapid  Rapid  Rapid immunochromatographic assay (rapid test) 
 
Confidentiality and unpublished data 
Specific issues relating to confidentiality of the data provided will be discussed between the owners 
and EFSA. 
Closing date for the data submissions is 26 April 2012.  
The data should be transmitted to EFSA in electronic format using the MS Excel® table TBtest.xls.  
Use worksheet RawData to enter experimental data for individual animals included in a study, one 
row per animal.  
Use worksheet TestSummaries to report the total number of animals testing positive and negative in 
test comparison studies, complete only the area in blue.  
A data dictionary for each column can be found in the first worksheet and the controlled terminologies 
and definitions are provided in Terms. 
Data submissions should be sent to this e-mail address: ahaw@efsa.europa.eu 
For inquires regarding the reporting format please contact us at: ahaw@efsa.europa.eu  
 bovine TB Test  
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F.   DATA RECEIVED – PUBLIC DATA CALL 
Data was received from both public institutions and private commercial organizations. A total of 54 data sets were received, a summary of the data sets 
provided is presented in table 8. The data was evaluated in agreement with the inclusion and exclusion criteria defined in the public data call. Furthermore, 
during the data analysis it was concluded that, because of the differences in test protocol, it was not possible to combine datasets from different countries. To 
be able to estimate all model parameters only datasets in which more than one population and at least three test results were available could be used. Data from  
animal populations selected based on post mortem results (infected /not infected) was excluded to avoid bias. 
Table 8:   Received datasets 
Data 
provider 
Workbook 
(a) 
Study 
identifier 
(a) 
Year  Country  Population 
(b) 
Study 
strategy 
Dataset 
type 
Test name  Skin test  Timing   Post mortem 
Asturias  data 
Asturias -
EFSA 
Asturias  2011  ES  OUT  Census  Summary  IFN-γ-BA  SIT cervical 
severe 
BEFORE  Culture or macroscopic 
lesions 
Galicia  Data Galicia 
- EFSA 
Galicia  2001  ES  OUT  Census  Summary  IFN-γ-BA  SIT cervical 
severe 
BEFORE  Culture  
Castilla y 
León  
dataCyLEF
SA 
CyL  2009  ES  OUT  Census  Summary  IFN-γ-BA  SIT cervical 
severe 
BEFORE  No post-mortem results 
reported 
Castilla y 
León  
dataCyLEF
SA 
CyL  2010  ES  OUT  Census  Summary  IFN-γ-BA  SIT cervical 
severe 
BEFORE  No post-mortem results 
reported 
Castilla y 
León  
dataCyLEF
SA 
CyL  2011  ES  OUT  Census  Summary  IFN-γ-BA  SIT cervical 
severe 
BEFORE  Culture (37) 
EURL  Population1  Example 1  2010  ES  OUT  Selective 
sampling 
Animal 
level 
ELISA-MPB70  SICCT 
severe 
BEFORE  Culture or macroscopic 
lesions 
EURL  Population1  Example 1  2010  ES  OUT  Selective 
sampling 
Animal 
level 
ELISA-MPB70  SIT cervical 
severe 
BEFORE  Culture or macroscopic 
lesions 
EURL  Population1  Example 1  2010  ES  OUT  Selective 
sampling 
Animal 
level 
IFN-γ-BA  SICCT 
severe 
BEFORE  Culture or macroscopic 
lesions 
EURL  Population1  Example 1  2010  ES  OUT  Selective 
sampling 
Animal 
level 
IFN-γ-BA  SIT cervical 
severe 
BEFORE  Culture or macroscopic 
lesions 
EURL  Population2  Example 2  2010  ES  OUT  Census  Animal 
level 
IFN-γ-BA  SIT cervical 
severe 
BEFORE  Culture or macroscopic 
lesions (62) 
EURL  Population3  Example 3  2010  ES  OUT  Convenient 
sampling 
Animal 
level 
ELISA-MPB70  SICCT 
severe 
BEFORE  Culture or macroscopic 
lesions (7) 
EURL  Population3  Example 3  2010  ES  OUT  Convenient 
sampling 
Animal 
level 
ELISA-MPB70  SIT cervical 
severe 
BEFORE  Culture or macroscopic 
lesions (7) 
EURL  Population3  Example 3  2010  ES  OUT  Convenient 
sampling 
Animal 
level 
IFN-γ-BA  SICCT 
severe 
BEFORE  Culture or macroscopic 
lesions (7) 
EURL  Population3  Example 3  2010  ES  OUT  Convenient 
sampling 
Animal 
level 
IFN-γ-BA  SIT cervical 
severe 
BEFORE  Culture or macroscopic 
lesions (7) bovine TB Test  
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EURL  Population4  Example 4  2010  ES  OTFH  Selective 
sampling 
Animal 
level 
ELISA MPB70  SIT cervical 
severe 
BEFORE  No post-mortem results 
reported 
EURL  Population4  Example 4  2010  ES  OTFH  Selective 
sampling 
Animal 
level 
IFN-γ-BA  SIT cervical 
severe 
BEFORE  No post-mortem results 
reported 
EURL  Population5  Example 7  2008  ES  OTFH  Objective 
sampling 
Animal 
level 
IFN-γ-BA  SIT cervical 
severe 
BEFORE  No post-mortem results 
reported 
EURL  Population5  Example 7  2008  ES  OTFH  Objective 
sampling 
Animal 
level 
Multiplex  SIT cervical 
severe 
BEFORE  No post-mortem results 
reported 
EURL  Population5  Example 7  2008  ES  OTFH  Objective 
sampling 
Animal 
level 
Multiplex  SIT cervical 
severe 
BEFORE  No post-mortem results 
reported 
Prionics 
 
120326ax1_
CH_B2G_L
S_BA 
FS2010_CH  2011  CH  OTFC  Objective 
sampling 
Animal 
level 
IFN-γ-BA  SICCT 
standard 
BEFORE  No post-mortem results 
reported 
Prionics  120326ax1_
FR_B2G_L
S_BA 
FS2010_FR  2011  FR  OTFC  Objective 
sampling 
Animal 
level 
IFN-γ-BA  SICCT 
severe 
BEFORE  No post-mortem results 
reported 
Prionics  120326ax1_
IRL_B1G_L
S_BA 
FS2010_IR
L 
2011  IE  OTHER  Suspect 
sampling 
Animal 
level 
IFN-γ-BA  SICCT 
severe 
AFTER  No post-mortem results 
reported 
Prionics  120326ax1_
UK_B2G_L
S_BA 
FS2010_UK  2011  GB  OUT  Selective 
sampling 
Animal 
level 
IFN-γ-BA  SICCT 
severe 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial1 
high risk  2008  IE  OUT  Selective 
sampling 
Summary  Multiplex  SICCT 
standard 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial3 
high risk  2009  GB  OUT  Selective 
sampling 
Summary  Multiplex  SIT caudal 
standard 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial3 
high risk  2009  GB  OUT  Selective 
sampling 
Summary  Multiplex  SIT caudal 
standard 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial3 
high risk  2009  GB  OUT  Selective 
sampling 
Summary  Multiplex  SICCT 
standard 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial3 
high risk  2009  GB  OUT  Selective 
sampling 
Summary  Multiplex  SICCT 
standard 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial2fil
eb 
high_risk_ar
ea 
2008  IE  OUT  Selective 
sampling 
Summary  Multiplex  SICCT 
severe 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial2fil
eb 
high_risk_ar
ea 
2008  IE  OUT  Selective 
sampling 
Summary  Multiplex  SICCT 
standard 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial2fil
ea 
high_risk_ar
ea 
2008  IE  OUT  Selective 
sampling 
Summary  Multiplex  SICCT-
SEVERE 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E high_risk_ar 2008  IE  OUT  Selective  Summary  Multiplex  SICCT- AFTER  No post-mortem results bovine TB Test  
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nferTrial2fil
ea 
ea  sampling  STANDAR
D 
reported 
Enferplex  120326ax1E
nferTrial1 
low risk  2008  IE  NOOUT  Selective 
sampling 
Summary  Multiplex  SICCT 
standard 
AFTER  No post-mortem results 
reported 
Enferplex  120326ax1E
nferTrial3 
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G.  MODEL DETAILS 
Materials and methods 
Latent class models have been used previously in the context of test diagnosis when gold standard 
tests are absent (Toft et al., 2005). The latent class model approach can be used for a binary latent 
variable,  , the categories of which are called latent classes and indicate the disease status:   takes the 
value 1 if the disease or infection is present and 0 otherwise. The outcomes of   diagnostic tests in the 
-th subpopulation are expressed using manifest binary variables,  , assuming the value 1 if the  -
th diagnostic test is positive and 0 otherwise,   (  in our case),  , 
where   denotes the number of populations. 
The model was used to fit four different data sets (Spain SIT, Spain SICCT, Northern Ireland and 
Ireland). In order to solve identifiability issues only datasets in which more than one population and at 
least three test results were collected could be used.  
Only the dataset from Northern Ireland was complete regarding the results of the post-mortem test. 
The post-mortem test results were missing for samples that were negative for the other two tests (IFN-
γ-BA and skin test, but also for samples in which at least IFN-γ-BA was positive. Three different 
scenarios were considered to simulate the missing data. 
-  Scenario I: post-mortem test will be 98 % negative when IFN-γ and skin test are negative. The 
proportions observed in the available data are maintained for the cases when both tests are 
positive or IFN-γ is positive (Table 9). The WG members considered this to be the most likely 
scenario. 
-  Scenario II : The post-mortem result is in agreement with the IFN-γ result. 
-  Scenario III : The post-mortem result is in agreement with the skin test result. 
Table 9:   Test results observed in Spain and Ireland 
  T101  T100  T111  T110 
Spain 2010  70  162  55  21 
Spain 2011  69  232  32  18 
Ireland OUT  88  326  326  21 
Ireland NOOUT  0  9  5  5 
T101, positive results to IFN-γ and post mortem, negative to skin test; T100, positive results to IFN-γ, negative to skin test 
and post mortem; T111, positive results to all; T110, positive results to IFN-γ and skin test, negative to post mortem. 
 
The model parameters include the prevalence in the populations considered,  , the sensitivities and 
specificities of the various tests in the different populations, denoted by   and  , respectively, 
. 
In this particular case, the  -th population counts ( ) of the different patterns of test results (in a 
total of eight possible patterns) follow a multinomial distribution: 
, 
where   is the sample size of  -th population, ,  , and   is a vector of probabilities of 
observing the individual pattern   of test results in population  . 
Y Y
p
j ij X i
p , , 1 i  3 p J , , 1 j 
J
j
ij Se ij Sp
3 , 2 , 1 i
j j O
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Then the probability of an outcome pattern  , considering that test  (IFN-γ-BA) and  (e.g., 
SICCT standard) are correlated in the infected and non-infected classes and  ( post-mortem) is 
assumed to be conditional independent from the other two tests, can be written in the following way: 
where    and    are  the 
measures of dependencies between the two tests for both classes (infected and non-infected). The 
model  considers  a  different  prevalence  for  each  population  and  equal  sensitivities  (
,  i.e.,  that  the  test  sensitivity  is  not  different  across  the 
populations) and specificities ( , i.e., that the test specificity is 
not different across the populations) of each test across populations.  
The Bayesian paradigm was used to fit the latent class model, considering non-informative prior for 
the parameters ( ). The prior distributions for the prevalence, sensitivities 
and specificities were considered to be   distributed, with parameters   and  . The priors 
used  for  the  covariance  between  the  tests  were  uniformly  distributed  between  the  limits  of  the 
parameters, which are derived from the sensitivities and specificities of the two tests and they are:  
 
Once the parameters of the model are estimated then the kappa ( ) measure of agreement can be 
estimated as follows: 
 and  . 
 
The latent class model was fitted using the statistical software R (R Development Core Team, 2009), 
the package R2WinBUGS was used to fit the Bayesian model, assuming conditional dependency 
between the test under evaluation and the comparator. The convergence was assessed using the CODA 
package (Plummer et al., 2006). 
Results 
The estimates of sensitivity and specificity of IFN-γ-BA of the Bayesian latent class analysis are 
summarised in Table 4. Sensitivity, specificity, covariance and agreement measure (kappa) for all 
countries (Scenario I) are shown in Figures 3–10. 
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Figure 3:   Prevalence  estimates  from  the  latent  class  model  for  Ireland,  Scenario  I.
 
Figure 4:   Sensitivities,  specificities,  covariance  and  agreement  measure  (kappa)  from  latent 
class model for Ireland, Scenario I. 
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Figure 5:   Prevalence estimates from the latent class model for Northern Ireland 
0.1 0.2 0.3 0.4 0.5
0
5
1
5
Northern Ireland - 2004
Prevalence
0.1 0.2 0.3 0.4 0.5
0
1
0
3
0
Northern Ireland - 2005
Prevalence
0.1 0.2 0.3 0.4 0.5
0
5
1
5
Northern Ireland - 2006
Prevalence
0.1 0.2 0.3 0.4 0.5
0
5
1
0
1
5
Northern Ireland - 2007
Prevalence
0.1 0.2 0.3 0.4 0.5
0
5
1
5
Northern Ireland - 2008
Prevalence
0.1 0.2 0.3 0.4 0.5
0
5
1
0
Northern Ireland - 2009
Prevalence
0.1 0.2 0.3 0.4 0.5
0
1
0
2
0
3
0
Northern Ireland - 2010
Prevalencebovine TB Test  
 
EFSA Journal 2012;10(12):2975  58 
 
Figure 6:   Sensitivities, specificities, covariance and agreement measure (kappa) from the latent 
class model for Northern Ireland. 
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Figure 7:   Prevalence estimates from the latent class model for Spain – SICCT, Scenario I. 
 
Figure 8:   Sensitivities, specificities, covariance and agreement measure (kappa) from the latent 
class model for Spain, Scenario I. 
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Figure 9:   Prevalence estimates from the latent class model for Spain – SIT, Scenario I. 
 
Figure 10:  Sensitivities, specificities, covariance and agreement measure (kappa) from the latent 
class model for Spain – SIT, Scenario I. 
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ABBREVIATIONS 
AHVLA  Animal Health and Veterinary Laboratory Agency 
EFSA  European Food Safety Authority 
ELISA  Enzyme-linked immunosorbent assay 
ELISA-B  Enzyme-linked immunosorbent assay with bovine diagnostic antigen 
ELISA-BA  Enzyme-linked immunosorbent assay with bovine PPD and avian PPD diagnostic 
antigens 
ELISA-MPB  Enzyme-linked immunosorbent assay with MPB70 diagnostic antigen 
EU  European Union 
GLP  Good laboratory practice 
GS  Gold standard 
IFN-γ  Gamma interferon test 
IFN-γ-B  Gamma interferon test with bovine diagnostic antigen 
IFN-γ-BACE  Gamma interferon test with bovine PPD and avian PPD diagnostic antigens and 
CFP10 and ESAT6 diagnostic antigens 
IFN-γ-CE  Gamma interferon test with CFP10 and ESAT6 diagnostic antigens 
IFN-γ-MPB  Gamma interferon test with MPB70 diagnostic antigen 
IFN-γ-BA  Gamma interferon test where the reaction to avian PPD is subtracted from the 
reaction to bovine PPD 
LBBA  Latex bead agglutination assay 
LCA  Latent class analysis 
Multiplex  Multiplex chemiluminescent immunoassay 
NILOD  OD obtained after stimulation with PBS 
NOOUT  Not officially free but no outbreaks 
NPV  Negative predictive value 
OD  Optical density 
OIE  World Organisation for Animal Health 
OTFC  Officially tuberculosis-free country 
OTFH  Officially tuberculosis-free herd bovine TB Test  
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OTFR  Officially tuberculosis-free region or province 
OUT  Outbreaks or reactors in the past 2 years in the same herds 
PPD  Purified protein derivative 
PPD-based IFN  Gamma interferon test based on purified protein derivative 
PPDa  Tuberculin PPD from M. avium 
PPDaOD  OD observed after stimulation with avian PPD 
PPDb  Tuberculin PPD from M. bovis 
PPDbOD  OD observed after stimulation with bovine PPD 
Rapid  Rapid immunochromatographic assay (rapid test) 
SIT  Single intradermal tuberculin test 
Skin test  Tuberculin skin test 
TB  Tuberculosis 
TBOF  Officially tuberculosis free 
T0R  Term of reference 
WG  Ad hoc working group bovine TB Test  
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GLOSSARY 
Accuracy: In the diagnostic test context, accuracy is defined as the overall (proportion of) agreement 
between a (new) test result and the true disease status (gold standard) in a sample of individuals.  
Bias: The extent to which a prevalence estimate produced by the surveillance system deviates from 
the true prevalence value. Bias is reduced as representativeness is increased  
Confidence interval: An interval estimate statistically derived from a sample. The interval estimation 
is  designed  to  include  (capture)  an  unknown  (true)  population  parameter  with  a  certain  level  of 
confidence  
Credible interval: the Bayesian equivalent of the confidence interval. A 95 % confidence interval 
states that the estimated probability that the process used to generate the interval includes the correct 
value of the parameter is 95 %.  
Diagnostic sensitivity: the ability of a diagnostic test to correctly identify a single infected animal. 
Diagnostic specificity: the ability of a diagnostic test to correctly identify an uninfected animal. 
Meta-analysis: A statistical analysis that combines the results of several studies that have addressed 
the same research question. As combination may increase statistical power of the estimation, results 
may be a more accurate reflection of the unknown property than those derived from a single study 
under one set of conditions. 
Systematic  literature  review:  Conducting  a  literature  review  using  prior  criteria  for 
searching/selection the literature with scientific tools to assess the findings from the published studies. 